CA2000254A1 - Stabilized compound of fgf-family growth factors and dextran sulfate and it a applications - Google Patents
Stabilized compound of fgf-family growth factors and dextran sulfate and it a applicationsInfo
- Publication number
- CA2000254A1 CA2000254A1 CA 2000254 CA2000254A CA2000254A1 CA 2000254 A1 CA2000254 A1 CA 2000254A1 CA 2000254 CA2000254 CA 2000254 CA 2000254 A CA2000254 A CA 2000254A CA 2000254 A1 CA2000254 A1 CA 2000254A1
- Authority
- CA
- Canada
- Prior art keywords
- composition according
- fgf
- dextran sulfate
- gel
- dextran
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229960000633 dextran sulfate Drugs 0.000 title claims abstract 11
- 239000003102 growth factor Substances 0.000 title claims abstract 5
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 claims abstract 24
- 230000004071 biological effect Effects 0.000 claims abstract 2
- 239000002537 cosmetic Substances 0.000 claims abstract 2
- 230000000087 stabilizing effect Effects 0.000 claims abstract 2
- 230000017423 tissue regeneration Effects 0.000 claims abstract 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims 5
- 102000008186 Collagen Human genes 0.000 claims 2
- 108010035532 Collagen Proteins 0.000 claims 2
- 229920002307 Dextran Polymers 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 229920001436 collagen Polymers 0.000 claims 2
- 210000004087 cornea Anatomy 0.000 claims 2
- 229960002086 dextran Drugs 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- -1 anointing Substances 0.000 claims 1
- 239000012736 aqueous medium Substances 0.000 claims 1
- 230000003385 bacteriostatic effect Effects 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000000512 collagen gel Substances 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000003889 eye drop Substances 0.000 claims 1
- 229940012356 eye drops Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229960005015 local anesthetics Drugs 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000008176 lyophilized powder Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000012466 permeate Substances 0.000 claims 1
- 239000011505 plaster Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 239000000047 product Substances 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 238000011012 sanitization Methods 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 239000012209 synthetic fiber Substances 0.000 claims 1
- 229920002994 synthetic fiber Polymers 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract 2
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000018109 developmental process Effects 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
- 150000002500 ions Chemical class 0.000 description 7
- 239000008186 active pharmaceutical agent Substances 0.000 description 6
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 description 5
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 101100511466 Caenorhabditis elegans lon-1 gene Proteins 0.000 description 3
- 108090000386 Fibroblast Growth Factor 1 Proteins 0.000 description 2
- 102100031706 Fibroblast growth factor 1 Human genes 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 2
- 238000013456 study Methods 0.000 description 2
- JGZVUTYDEVUNMK-UHFFFAOYSA-N 5-carboxy-2',7'-dichlorofluorescein Chemical compound C12=CC(Cl)=C(O)C=C2OC2=CC(O)=C(Cl)C=C2C21OC(=O)C1=CC(C(=O)O)=CC=C21 JGZVUTYDEVUNMK-UHFFFAOYSA-N 0.000 description 1
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 241000272814 Anser sp. Species 0.000 description 1
- 101100402341 Caenorhabditis elegans mpk-1 gene Proteins 0.000 description 1
- 101100294228 Caenorhabditis elegans nlr-1 gene Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001550206 Colla Species 0.000 description 1
- 108091026815 Competing endogenous RNA (CeRNA) Proteins 0.000 description 1
- 101001018064 Homo sapiens Lysosomal-trafficking regulator Proteins 0.000 description 1
- 101000657326 Homo sapiens Protein TANC2 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100033472 Lysosomal-trafficking regulator Human genes 0.000 description 1
- 235000010703 Modiola caroliniana Nutrition 0.000 description 1
- 244000038561 Modiola caroliniana Species 0.000 description 1
- 101100270435 Mus musculus Arhgef12 gene Proteins 0.000 description 1
- 101100219404 Mus musculus Calcrl gene Proteins 0.000 description 1
- 101100496106 Mus musculus Clec2f gene Proteins 0.000 description 1
- 101100366940 Mus musculus Stom gene Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241000746935 Nolina Species 0.000 description 1
- 241001024099 Olla Species 0.000 description 1
- 102100034784 Protein TANC2 Human genes 0.000 description 1
- 241000396377 Tranes Species 0.000 description 1
- HUMHYXGDUOGHTG-HEZXSMHISA-N alpha-D-GalpNAc-(1->3)-[alpha-L-Fucp-(1->2)]-D-Galp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)OC1O HUMHYXGDUOGHTG-HEZXSMHISA-N 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- ILLHQJIJCRNRCJ-UHFFFAOYSA-N dec-1-yne Chemical compound CCCCCCCCC#C ILLHQJIJCRNRCJ-UHFFFAOYSA-N 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- APVPOHHVBBYQAV-UHFFFAOYSA-N n-(4-aminophenyl)sulfonyloctadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 APVPOHHVBBYQAV-UHFFFAOYSA-N 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1825—Fibroblast growth factor [FGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
PRECIS DE LA DIVULGATION
"Composition stabilisée à base de facteurs de croissance de la famille FGF et de dextrane sulfate, et ses applications"
Invention de : BARRITAULT Denis CARUELLE Jean-Pierre COURTY José
INSTITUT DE DEVELOPPEMENT
ET DE VALORISATION BIOTECHNOLOGIQUE
Cette composition comprend l'association d'au moins une forme active d'un facteur de croissance de la famille FGF et d'au moins un dextrane sulfate stabilisant l'activité biologique du FGF. Elle est applicable dans les domaines de la médecine, de la chirurgie, de la cosmétologie, de la biotechnologie et de la biologie cellulaire, et plus particulièrement, dans les domaines où
les facteurs de croissance peuvent être utilisés comme agents thérapeutiques, notamment en cicatrisation et régénération tissulaire, ainsi que comme agents cosmétiques.
Pas de figure pour l'abrégé. PRECISION OF DISCLOSURE
"Stabilized composition based on growth factors of the FGF family and dextran sulfate, and its applications "
Invention of: BARRITAULT Denis CARUELLE Jean-Pierre COURTY José
DEVELOPMENT INSTITUTE
AND BIOTECHNOLOGICAL RECOVERY
This composition includes the association of minus an active form of a growth factor of the FGF family and at least one stabilizing dextran sulfate the biological activity of FGF. It is applicable in fields of medicine, surgery, cosmetology, biotechnology and biology cellular, and more particularly, in areas where growth factors can be used as therapeutic agents, especially in wound healing and tissue regeneration, as well as cosmetic agents.
No figure for the abstract.
Description
~ J V D J ~ r u x l ~ li U ~ r I U ~ U I U ~ J I ~ ~ * ;~ ' ~ n, * I
., ~f,~.`j5~ t~
I
;P~SIl'~ STAeILI~EI~ A ~/~5E ~E FACS~U~ : ~E CROIS~ANCE ~1~
LQ l;'/~MI LLE l:~F ~T kE ~EXTRANE ~ULF~Al'~, E 8E~; ~PPLICATI4t~J~.
L~ pré~ent~ inventlon se! roppe~ t~ ~ Un~
compo~ltlvn ~to~ b~e d' ~1 mo~n~ u~ f~e~eur d~
crols~nc~ dc 1~ femllle FGI~ et do d~xt:~ l~aa ~ul.fot~, ~ln~l c~u~ ~u,~ ~ppllcc~tior,~ de cett0 compo~tlon z~to~ e d~n3 ~e~!s domolne:3 de l~ m~decine, d~ l~ ch~rurlsio d~ 1~ co~méto-lo~ le, d~ 1~ blc~technoloF~e et de l~ blo v~ c~llul~lr~r et, plus partl~llLère:ment, clQns lo~ do~c .n~e ot~ les ~qCteL~rg l~J de CfOl5 ~nce peuvent etre l~t~lls~ com~ ~ ~g~-nts~ th~rsp~u-tlque~, not~ nt er~ clc~trla4tion et f~ 5~ r~t~on ti~ul~ir~, ~in~i que comme ~ent8 cosm~ :lqu~-~ 4 d~couv~rt~ d~ l~ f~m1 llo ~ B factaur i ~e cr~ anç~ des flbroblsste3 ~courc~@nt ds~5n~ P~
l'~ l' ~br~Yiatlon (~FGF~ - Fibrobln~t Orowth 4ctor~ a ~t~ f~lt~
ulte des e~.ttld~ de~ ~tlvlt~ ble:~ ~glq~u~o f~cte~r3 d~
crol$snnc~ obtenues dons lea extr~lts d' n tr~ rond nomorq~
d~ tis~u:s ou ~' or~s~n~s ~c~veau. hypovhj s~, r~t~n~. hunn6!u vitr~e, ehoroïd~, lrl~ ortil~e, re~n, ~oi~, pll~cents, or~ ut~ m. pl"oste~t~ o~ n~ e, et ). L~ dlv~r~it~
m~m,~ dl~3 tlss~s ~tudi~3 4t d~s c~lul~ tlmul~-sJ p~r ~:~3:~
t'e-::tl~lJrs ~'n v~ro Ct ln ~iYC~, ~ln~l que l~ ~r~ d n~b d' .~.~u1p~ ~ls rech~rche qu~ ont ~nd~pen~ mm~nt contsq~b~
c~rnc~ ti-on, b l' l:~o).~m~nt ~t ~ l' 1 ~n~ ti~n ~ JVDJ ~ ruxl ~ li U ~ r IU ~ UIU ~ JI ~ ~ *; ~ '~ n, * I
., ~ f, ~ .`j5 ~ t ~
I
; P ~ SIl '~ STAeILI ~ EI ~ A ~ / ~ 5E ~ E FACS ~ U ~: ~ E CROIS ~ ANCE ~ 1 ~
LQ l; '/ ~ MI LLE l: ~ F ~ T kE ~ EXTRANE ~ ULF ~ Al' ~, E 8E ~; ~ PPLICATI4t ~ J ~.
L ~ pre ~ ent ~ inventlon se! stop ~ t ~ ~ A ~
compo ~ ltlvn ~ to ~ b ~ ed '~ 1 mo ~ n ~ u ~ f ~ e ~ eur d ~
crols ~ nc ~ dc 1 ~ femllle FGI ~ and do d ~ xt: ~ l ~ aa ~ ul.fot ~, ~ ln ~ l c ~ u ~ ~ u, ~ ~ ppllcc ~ tior, ~ de cett0 compo ~ tlon z ~ to ~ ed ~ n3 ~ e ~! s domolne: 3 de l ~ m ~ decine, d ~ l ~ ch ~ rurlsio d ~ 1 ~ co ~ méto-lo ~ le, d ~ 1 ~ blc ~ technoloF ~ e and l ~ blo v ~ c ~ llul ~ lr ~ r and, more partl ~ llLère: ment, clQns lo ~ do ~ c .n ~ e ot ~ les ~ qCteL ~ rg l ~ J de CfOl5 ~ nce can be l ~ t ~ lls ~ com ~ ~ ~ g ~ -nts ~ th ~ rsp ~ u-tlque ~, not ~ nt er ~ clc ~ trla4tion and f ~ 5 ~ r ~ t ~ on ti ~ ul ~ ir ~, ~ in ~ i as like ~ ent8 cosm ~: lqu ~ -~ 4 ~ cover ~ rt ~ d ~ l ~ f ~ m1 llo ~ B factaur i ~ e cr ~ anç ~ des flbroblsste3 ~ courc ~ @ nt ds ~ 5n ~ P ~
l ~ l '~ br ~ Yiatlon (~ FGF ~ - Fibrobln ~ t Orowth 4ctor ~ a ~ t ~ f ~ lt ~
ulte des e ~ .ttld ~ de ~ ~ tlvlt ~ ble: ~ ~ glq ~ u ~ of ~ cte ~ r3 d ~
crol $ snnc ~ obtained don the leaps of n tr ~ rond nomorq ~
d ~ tis ~ u: s or ~ 'or ~ s ~ n ~ s ~ c ~ calf. hypovhj s ~, r ~ t ~ n ~. hunn6! u vitr ~ e, ehoroïd ~, lrl ~ ortil ~ e, re ~ n, ~ oi ~, pll ~ cents, or ~ ut ~ m. pl "oste ~ t ~ o ~ n ~ e, and). L ~ dlv ~ r ~ it ~
m ~ m, ~ dl ~ 3 tlss ~ s ~ studied ~ 3 4t d ~ sc ~ lul ~ tlmul ~ -sJ p ~ r ~: ~ 3: ~
t'e - :: tl ~ lJrs ~ 'nv ~ ro Ct ln ~ iYC ~, ~ ln ~ l que l ~ ~ r ~ dn ~ b d '. ~. ~ u1p ~ ~ ls rech ~ rche qu ~ have ~ nd ~ pen ~ mm ~ nt contsq ~ b ~
c ~ rnc ~ ti-on, bl 'l: ~ o). ~ m ~ nt ~ t ~ l' 1 ~ n ~ ti ~ n
2 compl~te to ce~ fsctcurs, expllq~2nt ll~ a~ultltu~e de;; non~
at de~ 51gle~ donn~ por ce~ ~il f ~ nlt~ ~utqur~ pour l~:~
d~31~ner. Il ~ppar6~t ~ln~ nten~lnt tl- f~on cl~lre qu~3 :
tou~s ce~ ~xtt~ait~ cont L~3nne!nt d~!~ faet~ r~ll d~ ~rol~snnce do la f~mlll~ des FQF3 et que cott~a f~ ll p~ut ~tre 2 compl ~ te to ce ~ fsctcurs, expllq ~ 2nt ll ~ a ~ ultltu ~ e de ;; no ~
at ~ 51gle ~ given ~ por ce ~ ~ it f ~ nlt ~ ~ utqur ~ for ~: ~
d ~ 31 ~ ner. It ~ ppar6 ~ t ~ ln ~ nten ~ lnt tl- f ~ on cl ~ lre qu ~ 3:
tou ~ s ce ~ ~ xtt ~ ait ~ cont L ~ 3nne! nt d ~! ~ faet ~ r ~ ll d ~ ~ rol ~ snnce do the f ~ mlll ~ of FQF3 and that cott ~ af ~ ll p ~ ut ~ be
3~ r~pr~nt~e por d~u:c br4n~he~3 pr~nclpal~ ~:
L~ premi~r br~nch~ t~ d~C It- ~ousl l~fi noms de F&F bQsiq~, de f~ct~ur de Cr~Oi~S~nCQ b oiqu~ Ou d- typ~ 2 a~ n po~r l~ h~p4rln~ ou ~ 3porln ~ind~ ~ O~c~th l~octoro (~UCI: II ), dG! f~ctel~r d~ ~rol~ nc-3 çl~r v~ du ~rvotau ou 3.5 ~r~ln~ lv~sd Crowth ~actor II 5~F X~ , d~ ~nct~3ut~ de crol~G~nce d~rlv~ de l' o~ll ou E;re-D~l ~ Ct~owth ~tor I
,, . . . . . .. . . . . . . . .
Z~ S~ l i'~T ' ~3 P ac t e~lr c~e c roi ~ nc~ d~3 ~ t r~Cyt o~ I X
A~F II, d~ fnctel~r de croiS~nCe d4rlv~ ~u co~ei1 t c ., D I o~ u~ l o deux~ a b 4r.che cl~ t om1 1 1 ~0~ t~ d~crlt~ sou~ les nom$ tle FCF ~1'd~ ou f~ctc\Jr 'j af f ln po~lr l' hépar1ne do ~ype I Ha~;F I , f~ctour d~rlv~ du cerve~u ou B~OF X, de fc~ctour de crolu~ nl;~ d~rive d~ 1' o~ll ou E~)CI; II, ~e f~ctollr d~ crol~s:3rln~ lo I~$trocytc~ u ACF I, de f~ct~ur de cro~ nco d~rlv~ u cart~lnEse ~CDCF I), etc. A tlt~ e r~r~nc~ b bllo~r~phiqu~
concerna~t le~ f~teur de crois~3~nce, n ~lt~r4 y R. L.obb, d~o~3 ~An~lytic~l Bloch~mLo .ry ~ a4 ~Ig~>o, et J. Courty ~t coll, dc~n~ ~h~m~ Blophy~. Re~.
Comtnu~ 10~-10~ ~98G~.
Ces ~u~taur~ ort donc et~ norn ~o, soit solon le ~yp~ d~ cellule~ clble$ utili~s ~f~ct ur3 cl~ ~oio~nc:~
dc:s fiDrobl~3t~ trocyt~s ou ~llule endoth~ , eve~
lq3 ~lgll93 r~pe~tlvem~nt FCF, AC~, ECO ~, oo~t 5elon lo .~OI,II~C~3 d' o~ ce fuct~ur ~:~t extrQit ~p~r e~compl~, f~ct~ur d~
croi~ ce d~r~v0 du cerv~u, t~ d~ 1~ r~ln~ s~u d~:3 ) yeu~ o~l-til~3, d' h~p~tocyt~ en cu ture, ~ lc;
s1~1eo r~_:3p~ctlv6~ment B~..F, RClCF, Ft~P', C3GE~, HI~GF, ~:t~. ).
s~lt encor~ ~ulon un~ proprl~t~ b~o~him c~u~ ou b~ olo~;Lque (facteur,~ ~ c~ol~u~ ce ~f~ p~ulr 1I h porl~ 0~ ~u î nct~r tumor~l ~n~;lo~ nlq~R ~TI~ ~au;c prin~:lp~ r, ,:'i-~ br~ncl-e~ d~ l~ t~emllle l~tAllt ~lor~ nomn ~ lon co~ æl~lo~ :
pr~c~ s ou 3ulvls d~ l~ mentis~n ~4c1dl~ ou ~b~iquQ--, ou :lo la m~ntlon l~typ~ - ou ntyps II~.
C' ~:3t ~n ~llv~nt l' ~t~ ~lt~ b o~oE~ u~ ~ur de~
C~llu~ n cultl.lre qu~ ee~ f~ct~ur~ on pll ~tr~a p~rlf~
L~ prem1~r~ cor~ct~rLot~qu~ phy~l~o- hlmique~ ~poldo n~ol~eulolre et point l~o~lectr~qu~) orlt ~t~6 pub~ s p~r Co~ipocl~rowlcz, ,r, Biol. Chem. ~EQ. 2~lY C147Y~ po~Jr ln ~orm~3 b~3Lqu,3,. ~t p~r ~i~rrlt~ult et coll., J. N~3uroscl. I9L 47~ 0 ( 19~z> pour lcl form~ ~c1de.
;~ '. ,.
'~ . .
, .
'. , ~ ; ' ~ ' ' '~ "'' ` " ' ' " :
' ' ' ' ' ' ' ' j ' '.'.
~- Zil~ r~ 5~l l~o purificntlon ~ homog~n~lt~ ~e~ d~UK fqrm~ u r~l ~ permi~ ~' ét~bllr l~urs ~tructure0 prlmolre~; E.~ch r:, ~t .-oll., Pro~. Notl. f\c~d. Sc~. I.JS, ~ ~!!S07 ~15B~), p~u~
1~ ferln~n 4~1qu~a, e~ Oirnenez GÇ~ SO et C411., 5clonc~
l~85~ l'385), po~r la forme ~c1~3. L~ lsol~men~ di~ls d~x forrn~ t~ ~r,~ndement felvorl~! por la dlSeouv~cte ~' un~
forte nfflnlt~ de C06~ fscteur~ pour 1'. h pel~ln~ ~t 1 ' ut 11 i~aS lon subsé~uent e d' un~ chrc~at ~r~phl~ d' ~ f lnl t Gur h~parine lrnlmoblll~e (Shlng et coll , Scl~nc~, .~, 1b 1296~ 9 ~1984) ).
In v~ tro, le33 FOF~ ~ont cnp~b e~ ~e ~ ln prol~ f~rntion ~t 1~ dlff~r~nci~tlon d' u gr4nd nonlbr~ ~e celll~lo~3 prov~R~nt ds tl~sus ~t e~p~c~:~ dlff~rent~. ~n c~ tcr4 les cellule~ flbrobl~.stlques, en oth~
15 ~plt~ la.~ s k~r~tlno~yte3, ehondr ~y~o, myo~l~
~stro~5~tq3, ~t~ n ~ n~lera ~g~ n 10 ~Ole d~ FGr::~
d,3n.s 1.~ survi~ neuron~le. In v~ ~rc?. 1~ propri~e~D
ncurotroph~ue3, anE5lo~énique:P ~t Si~ loonte~ dr~ FC;F.s ol~t c~ n;qnt ~t~ d~montr~-~s d~r\s de nombr~ Ix ~yot~m~
XO L~ r~l~, dqn~ la Yttlmlll4tlon ~ 1~ cl~oL~9d~ d.
1'~pid~trms, d'un extrE~it ~qu~ux de r~tl ~ p4rtl~ m~nt purifl,~ et contenont donc du FGF comm0 ~lnclpe nctlf, e-~t indlqu~ d~n.s 1~ br~vqt fr~n~ 3 n~ 2 4~ , OO~. L~ r~ e C~ ~
m~me ~::tr~it 5U~ cicutrls~tion d' ~pl h~llum d~ c~l-n*~ ~t ~5 indl~ué à~n~ le brev~t ~m~ric~ln n' 4 ~ ~7 435. ~pul~ ic~
de no~rellx br~v~ts ont ~t~ d~llvr~ d~ norn~r~u~ce~ -publlc~tiono s~lentl~lque~ ~3nt poru, ~u ~r~nt lo r~l~ d~:3 I~Crs purlflé~; t~n~3 la r ~nérc~lon ~t 1 ~l e~eh~rl3~ion de 1~ : .
p*~u, dl_$ V~iS~ x, de,s r,erF~, d2~4 09, d-~ muscls:~, ctc.
L~ plup~rt :1~ c~;3 trav~ux r~ult~nt d* 4 tron~pa~tlon de~
obsarvot ian:~ o~tenues t3ur ~s c~lluli~s~ n eulture ~u;~ m~m~4 1 U l ~ v~ ~c7, /~ln~l, 1' ~ppl~ ~ation ~op~quo ~ ~3F ~ul ou 1' utlli.~atlon d~ polyln~r~, t'~pon~ , o ~1A OU ~e pl~mp~:~
,35 p~rmett~nt l~n r~larg~ t de3 FGF~, ~Ut lnduiro urla n~oan~rl o$~n~se ~t url~ r~n4r~t lon n~ ~U~ ou cut~n~e.
,: . . . , :. : ~
'' ; , ' ~ ,,: ' ' ' ~ ' ' ,' ' , . ' ' '' ' ' ' ' .. , ' . ' . ~: ' ' 2~
'.
~ pendont, 1' nppllcot lon topl ~o de FGI: ocid~ o~
l)~ ,l~u~ olt :~o~ nt ~tr-~ lt~r~t'Lve pol obter~lr 1~ cffet~
mQ:clm~l.Jx. C~cl 6:3t prob~blement dC~ 4 u ~e ,ln~obll~ t~
ther~n~qll.~ de 1~ rnol~c~le, une protéolyr p~r dlæ3 en~ym~4.
!~ ~lnsl qul ~ IJn~ lnteract~n ~ntre le~ FO c et 1~ lyco4mlno-zlycones, col~une 1' h~p~r~ae sulfate ou p ot~oh~ r~n~
sulf~t~, de9 meml~relne~ eellulslri~a ou ~ ~ mambr~ne~3 balcQle~, e~r~fn~nt une lmmoblll~tlan de~a F~F~ c.uvant emp~cher leur acc~ ~ux r~eepteur~ e~llul~ro~. A c~ propo8, un~ ~b4ence ~e 3tlm~Jlotlon de l~ cl~z~tri~tlon p~r ~ FGF d~ p2,~1e~
profon~-3 ~ ~t~ r~pport*e (J. D~rm~tol. 5urg. Oncol. t;, 6 l 7-~25 ~19~6~ ) lor~que le Fap s~ul ~t elpp ~qu~ d' une m~nlbrq toplqu~, ~lors qu' ur.e pr~l~ f~r~tton fl~ o~lu3t~q~ ~t ~yobl4s~, lqu6~ t obtenuR lor~qu~ de~ ep n~ eonst~tuée~
1!~ d' ~lc~ol polyvlnylique l~nbib~ ~e ~GF ~o t oppllqu~ sou~ 1 paau (J. ~ lol., 1~0, 12~9 C1985).
On ec~nst~te p~r ~llleure qu~ ~ FCF, ~u~ol b~n sous ~ forme ~cl~ F~;F) ~u~ ~OU5~ 9~ orme bz~;lque ~
~ue 1' on conserv~3 h~bltuelle~m~nt ~ -80' , p~r~ d-~J~ ;on ctivite lor~qu' 11 e3t ~m~né t. -20'~ co ~ ~ templ~r~tur-~
bi.3rlr, ~.
~1 ~pp~r~it donc 1~ c~31t~ d~ 3t~blll;~3r 1 f~cteul-~ ds cro~s~4nc~ F~3~ pour p~uvo~ ~nvls~ser r~ mont leur;, ~pplle~tiorl:s. P-~ur le ~ppllent~ no ~n vf ~o L'5 notllmtnent, 1 s~r~lt avt~nt~eu;; qu~ ~odG~ d~ ~t~ t lon l~ulese permettrc~ un relc~r~ lant du P ;~, Cl3 d~rn~qr ~even~nt un aE~3nt mito~;~ne loco.l, r~ntr ~nt d4n~ le8 proces~o n~turq~l~ d~ r~ n~r~tion c~ll lult~.
t~ 1' hol~t e ~ctu~ , compte t~ ~u d~ 1' lmpc~rt~nc~
d~G fnct~urs de cro1 ~s~n~e dor~s lo~ do~ iln-~ pr~c~eé3, on ~lt q~c baAucoup d~ t~nt~lb~ve:~ ~ont ~f ~ctu~a pour 3t~blll~r l~ CFs, m~ eonn~l~ ~nc~ 3 la D~ ent~3, il n'y ~ pQs ~ncoro eLI ~ c~ o~r dl3 propo~tion concl ~t~ ~t 4~t1~fo1~nnt~ pour ~t~b1114 ~r l~o ~ pour :3'j qu' 113 con~e~-v~nt l~ur ~ct1vitS r.on ~- L~ nt ~n ~ ro, mol~3 ,s~ m,~nt l n vi vo.
.~ . : . . . .. . . .
. . . . , , : ~, . , :
:, ' . , '~ .' . : :
, . ,', :. . . , ~ . : :
.,, . r r ,'Zi3~
L,~ pr ~sent ~ ~u~vent lon ~ppor~ , quant ~ , un~
t lon ~u pr.~b~ oY.~, cor~ t~nt ~ eoc~,on un ~ t r,:)n.
.,~ulr~J~.~ aux F~i~s, 1~ con~ itlc~n r~ ~r~t~ ~t~nt etclbla ~u ~to~ M~mæ ~ temp~r~tur~ nbl~nte.
L~ pr~nt~ lnventlon ~ ~onc d'abord pqu~ obJ~t une ~o~npo~l t i~n co~npren~nt 1 ' ~3.~0clot ~L n d' ~u molns une rOrme ~ctlv~ ~' un ~cteur d~ c~ol~4n~ d~ la ~ml~l~ FGF ~t d' 31- moin.~ un ~extr~n~ eul r ate st~blll orlt 1' ~Ctlv~t~
blelo~;ique du FC;F.
1~) Le~ de:ct r~n~s 6ul f ~t es ut i l l ~ ~ont d~ 3xt r~n~e .~ulfat~.P t,y:lr4~0lub~ , $n401uble!~ cn i~lou o~u~ux olJ r~-l3 In-'~ 3 IJ ~
L~ tr~r,~;t ;ulf~te4~ ~lub oer qu-t 1' oo peut ~It~llsal- p4ur 1~ mi:3~ en 02uvre ~e 1' ~ Yon~lon, ~nt do~
1~ p,r,~uits ~olJr~nt~, ou~ ~ont r~i-r4:;~nt~ p~r 1~ forrr,ul~:
1 C~l~ . ~
~ n 0~ '.
d~n~ u*lls u~ h trols ~roupe:~ hydro yl~ du n~Ot~r ~onom.~re s~"lt ~ t 1 t U\~!~; p~r cle.,, ~roup~ -0-503 ~forme ~ld~) 0 .5 - C~-.;f~ (f~r~ ;le ~ . Le:; produl~s oo plu~ u~ .,ont d~.~p~ lt.~l~$ sou~3 forn~a d~ :~el:s d~ ~odl ~
L~3:3 produits pr~f~r~ p~Uv~n ~tr~ o polyn~br~3 ~e ~n~ ,tA M~ cul~lr~ cQmpr~se ~nt~^e 1~ 000 ~ ~00 I~ O, nt.~ ntnt nt ,2r~tr~ .~ 000 et 5VO 00~, tol3 ql,l~ 1' on p~ut e.' ~n .~) præc~ kr ~up~ d~ 1~ Socl~t~ ~ICMA ~R t` ~07~, Dl~39~, ~OC~ 7 l 40, ~3~06 du cPt e~ u~ l9~S~) .
L~3~ xtran~ ulfAto~ lnfi~c~l bla~ 40nt ~,e d~:~tranæ~ l3cul~t0~ r~tl~ul~e selon 13i~ proc~d~!~ h4bltu~13 ~e ~t~ 3.,~t,i~n, cn portleull~r ~ ld~ '~pLchlol~hydrlnk, ;~r ~5 .
.. ,.. . ; ' ,. ,, . ' : ' ' , . ' , ' '. ' ' .'': .' ' ' ~ . thp ~ , C ~ I IX ~;l C! r l~ r mu ~
Q
~1~ O ~ CH
OH ,~O
~H ~ O--j 2 ; 1:! --O~
CH-OH ~)~1 ~-- o OH
;:
1_1 HO ~1 \
O - C H ~ o > ~ 2 :
~2 ~ \-o 1 1~0 ~!~ C)~ ~ ........ 1 0~ 1 ow ~s l.~c~ un~ ~r~ on ~s group~:~ hydl-o~yl,2,~ ~ ,t ; . ub~t 1 t.l~S~ par d~ ,r~up~ 0-503H ou 0-50; 11~ p~ erlt 5~! pr~ ~nt~r ~ou~ form~ d~ poudr~ ou e ~el~.
Colr,me ex~pl~ cl-~ e~E: d~xtrnr~ ~ ~ulf~to3~ on p~l~t clt~r c,~lui commercl~ p~r 1~ ScelA 6 51~ oU~ 1 r~r r.~r~ tal~u~ 19.''tt~ n p~Ut ~ 41~ nt o~e~
tf~l:a d~3;~tr~nH~ ~e1 on lf~ p~otc~colel d~r t p~ Mll~t ld.~ J. ~t cctll, An~l. Blt.?ch8~n. .LQ.~- :304 ~ 0).
~ \u ~ln t~ eompa~iltlon ~ on 1' lnv~ntl~n, 1~.3 t r ct r\ t~ lJ l f 4 t es h y P r o~ o l u~ on t ~ n t s ~ un ~
~ollc~ntr~tlc?n dta ~ FO m,~ p~r m~ 1111tro d~ m~l4r"7,4 n~3l. L~ ~nc,¢rltrat1on ~o~ ~xtr4r~; t~ulf~tfa~3 ln~all bl.
:i~n~ ., m~lf~ t~ t~Rxtrant~s~tF~$ p~ut 11~ , ~ ~æ
,~ lJ:,;t-',l,~' a 50C~ m~ F~ m~ 1 l l l l t ro ou 2 r~ ~ de n~ n~ r l n~ l .
',.
. ~
,,;, ,j ", , i ,.
'; ' ' ' , : '"~' " ' ' 2~;~r~ 5~
, .
1.~ eompo~ltlon s~lon 1' ~nvent on contlenS p~r aill~ur.~ ~vanto~eusernellt des qu~ntlt~a; ~fsct~vra ~ O, ~1 r g 3~0 Jl~ t' ~u nlolns une forrn~ ~ctlve do F~ p~r mlllllltre ~u gr~mme de mblan~;e final ~F~dextr~no ~ fAt~.
L~ d~xtr~no~ oul~e~te3 ut~ ~ pour 1~ ml5c en o~uvro ~ prb~nt~ lnv~nt~on ~er~en~ d~ ~upport b 1~
ml~r~tlon ~t QU ropouplem~nt cel~ul~lr~ Ils pouv~nt ~tr~ :
lncorpor~s dan~ tout~s form~ do p~n~o~ nt~, ou ~ncorr sur des fll~ de ~uture utilis~s en chlrurE~ , d~ me~nlbr~ que 1 1~ fact~ur ~56aoci~ ~ c~ dextrcn~ ~ulf4t~ o~ f~ct~ur tout :seul pui~ lf ~u~r Yer~ los ti~ u~ ~l 1 L~3 ~cteur:s d~ c~olss~ncQ F~ utl~ d4n:; cett13 invention p~uv~nt etre d~ prodult4 n~ rolo, ~s prodult3 u:; d~ :;ynth~e~ chl~iqlle.~ ou dc3 pro ~Lt~ obt~nl~3 p4r ~e;:~
I!; techniq~es ds recombln~l~on ~ tlq~lo. Il~ p~uvent ~tr~
a' ol~lgine hum~lne ou prov~nir d' A~tre3 ~rn~lfere~ ~t non n~m~l f ~re:~s. I l n' ~t ~én~r~ler~ent p~ ~e~aslr~ d' ut l l l: 13r 1~ t'~ct~ r ~utologu~. En ~f fet, 1~ hol~ ~~ de conse~
v~tlon de 1~ ~tructllrç de~3 F~F~; ~u C~UF de l'f~olutlon, n!~1 q,~ Q~ ~t~lde~ ur le!~ prop~ t~a ~n ~lero et in ~
ln,~lqu~l~t qu' lL n' y ~ p~ d~e sp~clflclt cl' ~p~c~ pour le;.~ ~
dc~ fOr~lle3 blo~ctive~ da:3 ~ril~ E~ l~nt, orl utlll~a 1~3 ~ ,t` ~oua ~ for~n~ purlfi~e ~el~e, ou ~o ~ 30~ ~orm.3 baalq~le, ou encore un m~l4n~;e dQ:3 d~lux form~, c I ~2neoro un ~rl~5 ~U
;'~ un ~n~loé5u~ u mo~n~ 1' un61 do ~a~ fo~ ~ , L~ ropport ent rc~ s PCF~ 4clde et ~n~l~uo d~n~ ~, form~ n~ p~l~t Atr~ d~ n' lmporto quQlle v~laur ~ntt~ 1 ~ daux for~e~ pur~, Dlff~ront~ proc~d~7 do purlf'l ~lon pau~nt ~tre utll~s~s pour l~lar ce~ dcux f~rm~a~a d ~CJP ~ p~rtlr d~ . -oour~ n~turell~fi Cr~tlno. c~rv~u, h~ ~elphy~, plqlc-3nt4, r~in, ~tc. >, c~ proc~ t~nt eonn~4 t. 4y~nt 4t~ d~crit.
par dc r~ombrollx ~t0ur~. LQ m~thod~ pr ~r2~ t c~llo déçrlto pe7r ~;ou~ty ~t ~oll. d~ns; (~Bloc1r ~G7. Blophyiil, R~3.
Commun., ,~, 102-lOB ~lg~ m C~tto r ~thod~ compr~l7d un~
~5 ~topc ~on~3l~t~nt 0. trc~lt~r, pen~4nt ~n nuit, do l' ~xtr~lt t i61al.1~ ,7n ~ pr~:3t7nc~ d' ~elt~7~1 ~c~tL~ ~ ~ p~t 3, o~ccl~lan~
, !, ~' . ; ,; 1 Z~ 5 ~
~n~l tout rl-~qu~ d~ ~ontomlntlti~n vlral ~, ~t ~ ~ondulra IJne p~o-iflc~tion p~l~ chrom~to~r~phie ~ur h~ 3rlne lmmob~ e p~rlne ~eph~ro.~ HAR~1ACI~. Loo c ~ix f~rm~ oeLde ~t b~slque d~ FCF pe~vent Qln~l etre 1~o7 ~q ~ ~t f~par~4s~ nvec le.~ 4utres prott~lnl~8 OU lnd~vlduell~men , e3ve~ un ~b~r~ d~
plJ~et~ suffl!3~lnt pour atre d~b4rras3~e~ o ~u~ntlt~5*
~lgn-~lcatlv~.s d' autr~ mdt~rl~l~ con~ ~nelnt~.
~es ~nalo~ue~ ~ynth~tf que~ ~u ~0~ p~uvent att~e obtenus pnr synth~ chlmiqu~ ou pnr ds t~chnlquo~
cll333~c3u¢:~ d' ~nz~nl2rle ~n~tlqu3, t~ll 1' oxpr2!4~0n :le g~r,ea synth~tiq~es ou l' ~pr~slon ~ n~o mocl~fl~ pcr t~ z3-3 diri;~ d~ lte~ ~p~ lq ~
To~lt~a 1~ formQ:~ de FGF obt- u~n d' ~xtr~lt a tl~ul4irr~ p~r in~éni~rl~ nétlq~l~ ou p~r synth~
cnlrnlque, qul ell~:~ 41ent ou non ur~e ~tr cture modlflée, ~lr)sl qu~ le~ fr~gmenta en d~r~ t, p~ v~nt ~ro ut11s~e~
~ou- r~'~aerYe qu' elle3 4~o~ent ~ctlve;l~ bl log~uement - un te.~t ln vi~ro cl~;nm~ celui pr~po~ cl-clp ~ p~w4nt etr~
utlli~, 2 ~ 3 as ~ t i on !i~ de FOFc t~ t 4 cl~x ~ r~ 3 ~s~.J l f ~ t d~ nvellt~on p~u~nt ~tne ~ncorpor~e~ dsn~ d~ Uppvrt~
phy~1o1o;31~uem~nt ~c- ~ptab1e~ p~ur d~ ppllc~t~on~ ln v~v~, pl1c~t1on ~st une elppl~catlon loc41 , p~ vo1a e;;tenno ~ur 1~ pa~u ou 1~ co~ e, not~mm~nt pO~I ~ ~cc~l~r~r 1 clcc~trl~s~t~on d' un~ pltlie ~t 4m~}110rsr ~ qu411t~ do cett-~
~lcatri.~tion, ou ~ncc~re p~r v01~2 lnt~r ~ l~ur 1~ t or~n~3 du oorp6~, p~r ~x~mple d~no 1~ t ~ltem~nt d~ 1' uLc~ro ds 1' ~stom~ç. S~lon l~s~ type~ l!t l~u d' c~ppl lc~tlon, l~a coml~o~1tion3 Compr~n~nt 1' ~a~ocla~on ~ ~ F~F~ ~t d~
3(~ d~:;trnn~a oul~a~Q~ ~eront dlf f~r~nt~. . 1~ n~lt~ro ~ d~
3upport~ p-3ut ~trQ c~ctr~ ont v~rl~bl at d4~and ~onc du typa at llcu d' uppl~ccltion, ~t prut pt~ ~Idr~ la forln~ Jn lit~uldl~, d' un /i~,'9s4~ un~ cr~me, d' ~ ~ ~ol, ~ n tl~su ~II)p~ n~ comn~o un~ ~o~o, un tull~ ~oci~t~on:3 ~G~'3-d~xtr~neo ~ulfnt~e ~ lnvention p~R~V~ ~ ~gal~ n~; ~tr~
lncorpor~e~ ~ un~ tln~ eon~tlSu~ ~r un collos~n~, qu~l ., - . . . ~ - ~ . :: ., , :
:.
z~ z~
qu' ~n solk le typ~, ou ~ncore, comme Is~ i~ t Ci-d@~ 3, recou~n lr de~ rlls de ~utur~
~e3 forll~ulQtlons ~qu~u,soR d~ ' $nv~rltlon 1;eront o~nt~eu:~erl~nt d~s conp~sitlon~ conten r.t. d~ t~mpons et sels permettant de m~int~nlr 1~ m~l4ng~ ~u vol~ln~ 'du pl~
physlolog1 qu~ et ~u volslnc~ de 1~ for q~ lon~que~
phy31c>10s:1~ue ~olt pH de 6, ~ t~ 7, 4, ~t foree lonlq,ue ~ O, 1 ~ O, 2 M) . On peut ~Jouter ~ compolsl ~OA dl~8 ~ddlt lf8, comrn~ ~e~ nn~th~lqu~s loc~ux ~p~r ~x~ pl~ a lldoc~Ino)~
d~o 6ub~3t~nce b~ct4ric:~st~tique~ ~par e ~pl~, do~ 6el~s de s~dlum, d' l~rsent, 1QU~S d~rlY~a~ o~ t~Ol~t u~f4~1e3~1n~ e~3 produl~ t ~epti~nts, ~comm~ B~tad~n ~, deJ ~n~lblotlq~t~;
~p~r c:;~m.ple, 1~ streptomyclne), ~e~ pr t~n~ ~t~que~ ~p~r ex~ple, ln ~rum albumin~ ou l~ flbron ctin~, de m~me que de t coll~n~ta hydr~solubl~.
Une tall~ cornposltion ~qu~us~ r~nf~rm~nt ~u mo~rls un f~cteur ~CF ~ssocl~ 9 a~l moln~ un d~ tr~n~ 6ulfat~ . -hy~ro~vluble ou insoluble, p~ut ~tr0 u~ ll~o dlr~oct~n~qnt 0n solutl~n, 6tn 41~ro5tol, ell onction, en lo lon, ~n poud- ~ ou ~n 591, OU ~el~vlr d~ ~;olution pour ~tr~ ln lus~ don~ urt :;upp~rt ph~r~nacel.~tlqu~ment ou co:~;rn~tl4u~3m3nt. ac e~ptoble, t~l ~tl' 4n~1 pomm~ds, un~ crbme, un ~el de re~ n o~ un ~1 d' un~ ~
aut r~ n~t ur~, ou de 1~ t lne ou 1~ ~regn~r un ~ e ~olla~n~, un ~ ' unq ~utr~ n~tUr~, R I d' ~utres ~ul~qt~n~
~5 fol34nt ~on~tion d' éponge, un pQna~e~m~nt un ~uppore d~
p~nsement d~ recouvrement ou un biom~at~ ~ cle~vtlnt fn~orlsor dir~ct~m~nt ou ~ndlre~ement 1~ r~p~rA~ ~on tlo4iulalr2 tp~r ax~mpl~, un fll de ~ut~ro chlrur~Slc~l) ou ~l;ro ~ppllqu~
~ur d0~ flbr~ na~ur~lleo oU rynth~tlq~ ~.
"~O Pour d6!s oppli~t~or~ r 1~ I~U, lo~ ba~ de cr~m~ ou lotlon~ utilis~ trcldltSonnq Llo~r3t p~uvent ~tr~
utlli4i6~s, Comme 1~ l~nolina (Silv~d~n~ ~ M~arlon plu:~
par~t lcull~rl~mant pcur le!.5 bru~,~sJ Aquql ~or Puk~2 L~bor4tor1~0 ~;o~th Norw41k, C:onn~ctleu , l~qu~
~L' Or~l) ). Leo ~rbm~:j peuv~nt cont~n ~ 0 prot~1no~ ~p~r ~:~elnplc, ~oll~ n~ tins2, ~te. ).
, .
``` z~ 2S4 - .
L~ p~ns~m~nt. peuvent ~tre d e pono~mento cl~
toxtll~.i, tls~u~ .~ynth~tiques ou ~pong~ , o~l ~ttr~3 ~ 3 protluits n~t~rels s~rvant de r~couvrem8 t de pl~ Sp~r e~ rnple, de3 ~els de coll~ ne, cleR del~ e4~. d' orl~lne ~ni7~1a), L~ compos~.tion FGP`-doxtr~n~ ulfot~ on ~olutlon do~t pouvolr lmpr~n~r ces dlf~ n~ orma~ d~ pon)3~nts, de monl~re que le fQ~t~Jr F~F pul~ t ~ on contaet ou dlf f~lser s~ul ou e~3 o-;ie c~u d~xtt-~n~ 6u fat0 ~squ' nu:c tls~u~ clbleo. L~ co7npo91tlon ~lon l~ n ~ ntlon ~3t lo ~ppl~qu~e ~lem~nt de m~ni~ro ~ pouvol ~tr~ ~slnt4n~0 .~ur le ~ite de 1~ bl~s~ure et :sur le~ b~e r~o o~l~art~ Y~
m~lntlen de 1' hyclr~tatlon ~lon lo~ ~ee ngq~os ~e 1~ ho~m~ du m~tier, p~rt~u~l~rem~nt ~l~bo~ d~n~ le dom~ln~ d~s greff~ ~c ~ pe,~u. I.e:; p~næ~ment~ ~ec u~lf~ peuvont ~tro lr/~pr~n~ d~ 1A m-~me m~niere, ~dsorb~o u recouvrlr un ~upport n~t ul~el ou :3ynth~t lqu2.
Pou~ le~ ~ppllc~tlon~ sur 1~0 cvrn~o, 1~ v~h~cule dvlt ~trR compo.tlbl~ av~ t.ol~ranc~ cul41re~ on c~t6~r~
co~nrne ~ mp~ d' un tel v~lllcul~ pro ult commc~-cl~
:;OU 3 l e nom de ~ L~er l bu l e ~J ), l e~ t on~ l l n~
solut iVI- lsotonlq~ue:3 ~p~l~ e:;~mpl~ 40c~dron ~1~1erc~
5h~rp-Dohm~) ou de~ quivalents), ou on oro ~ou~ form~
gel forrnant un ~cran p~t~ct~ur d~ 1A c rn~. C~3 v-~h~culo.s p~uv~nt cont ~n~r ~3alomen~ dw ~e ont~ c n~orv~t*ur~ comn~,~
3 ;:hlorur~s ~ ben~yldim~thyl 41kyl ~ mol lu~ ou l' f~thyl~nQ
di~mine t~tr~ac~t~t~3 dl: sodium ~DTA).
Il peut é~ ra~nt ~r61 ~ouh~1 tlble d' lnclur~, ion~
de~ llposom~, une ~s~oclclt~on Ft;F-dox~ An~ 4Ulf~t~
hy~rosolubl~ dc 1' lnv~ntlon. C~3 llpo~ ,n~ pauve~t dtr~
qlorEs lncorpor~ d~ns le~ compo~ltlono ~:rita:~ cl~e~u,3, p~r ~x~rnpl~, cr~m~:a, pc)mm~d~o, utll~3~ ,~ llo~ qu~ s ou pour 1' iMp~ ;n~tion d~ ,~upport~, ~omm~ ~:~ pan~m~nt~.
n~ la c~i3 o~ l' on ut~ lloo d la d~ctr~neo ~ulf~te:;
lni~ol~ ~; les, '~eu~-cl p~uvont ~itro s1mpl~ ~nt a~o~ i3 a ou bicr ~ talleo 4~0clatloao p~uvont ~ro lnelusoi3 ~qn~
deo i3upporti3, ~omme d~ cr~m~, de~ ~4J ~tln~o ou d~,3 gel:3 de .~: , ' `''' ` '"'' ''' '' . .
,, '' . :. . .. ~ : , '' ;. , ,:~
;Z'lJ ~;~q.'D2(5 collr.~z~ s, ~1~ etre ~ppltgu,'~,s fii~ fl~r~ ~ynth~tlqu~
ou rlatu~ e~ ~f~ls cl~ ture?, ou l~iF ~n~r ~ upp-~rts habl.u~ls ~-~e p~n~e.~ent~ recouvr~m~n . L' lnclu~lcn de ~ s de:~tranes sulfata3 ln.~ lubles peut ~iQ ~lro p~r l~blbltlon ~/ou ~dc~lti~n d~ un~: solutlon de coll~ e~n~ ~t ~llfl~ ~tLon.
On p;:ut notamm~nt ~!ti~l~er le ~ot~3 op~ e~t31re d~crlt 4~n~; le tre-~t U5-A-4 0~0 0.~ ;u~v4nt lsquel n r~llse ~In~
co~nposltion ~,t~ lflé* ~omp~slt~ d~ns ~u~llo l~ p~rtl~ an CC`t')tACt nvec la ble~ure a~t couvert~ ~ coll~n~ r~tlcul~
~0 ~\Vf~ n ~lyco~mln~gly~n~ SI~n~ 4tant o~teflu par ,~ d 1,11 t 1 on d ud 1 t g l yc oo~ ~1 no~ 1 ye anh ~ u c 1 1 Qs~n~ ~Oa ub ~nslhmbl~ ~tant pr~ Iplt~ ou r~t1cul~ p~t~ du ~lut~.~rolddhydt~. ' Par 0111~ , co~nme ~ndlqu~ ~-dos~ll3~ le:~
;!~ C~ !rlpO~ n~ :3~1~n 1' In~nt1on p~uv~nt ~;3ol~9e~t p~ ,:s.~nt,:l ~4u~ un~ f~r~e appl$cable lc ~letn~nt p~r ~ol~
Interr*, por exemple c~.~m~ pl~tr~ ,n ~4tro-ont~rlqu~6 cu pO~ b~; lyophll15~.e.a ~nclusas ~u nan d no das z~lule3.
LA pr~pdr~tlon de~ co~po~ltl ns de tr~lt~merlt ,~
ic,~trl.~4t~0n :3e10n Ll LnV~rlt10n ~:3t, d Un~ ~n~ g~n~r41~, r ~ e ~elon de3 m~thodQra cla:3~.;lqu~ blan co~nu~3 ~n nl4u~e. L~:~ dos~$ ~ ~d~nlnl~tre~ o l~ur fr~ql~ence .sont or1~ 3 not~mtner~t :se10n 11ImpDrt~t.~ d~ l~ pl~lC.
Enflrll ~ COi~tpOi31t10lll~ 5~310 ~,' ln~/entLon kl~ou.~ent lert~ent ,3pplic~t lot~t dah~ l~ dom~lno o~m~tl~ue, pour ~m~IIor~r~ t4t d~ l~ p~au. L' ln~ttnt on ~ nc ~o~ m~n~ s ~mpo3~tlon~ co~t~tn~nt, n~ un ~uppt~ t cosm-~tlq~emerlt ~c~lpt~ , une a6~io~;14 lon pr~clt~ FCF--tran~ ~ultat~:, c~tte c~poGlt~on s~ pr~s~rltAnt not~mrnent, i~; form~ cl¢ l~tlor, ~al ou cr~t. .. ....
On d~crlr~ molnt~nortt l~;~ of ~t~ d~ d~tl-~tn~
6ulr~t~ UI~ la prot~ct~ot~ 3 1' ~itl~l ~t bLolo~l~ue d~3 r t~ ;.
L~ h,~ v~l u~ n ~1 Y~ t ~ c t l -~ t -~
h~ ue l~ 'CF3 s~2nt d4c~1te,3 d4n~ dc no~nbreuo~.
~IL>lic.~tlor~ t ~lle.3 ~ont tout~ ba- ~ olt ~r un ' , ,, ' , ' ", ' . i ' ' .1 , , , ' Z~
l~
m~.lsuro (.!e l' b~lgrrlent4t l4n ,lu n~br~ da C l~u1~3 ~nd~ p4 rl~:, d-~..e:, crol3is4nte~ C1~3 farteur6 4~10ut 4 ~u ~lieu de cultl~r~ d~ llule~, ~olt ~ur un ~ 'nt~t~on do 1' lnl:orpo~ tlon de thymldine t~ltl~e d~ ~ DIl de~ cellul~J
3t Irnul~r:~3 p~r lr~ f~cte~r d~ crol6$~ne~. D~ns 1~ u:c protocolc, ces ~u~ent~tl~n~ on~ d~p~ ,d~nt~ de 1~ d~ d~
f~ct~ur ~ jo-lté~, ~t 1' on peut ~onc et4t Lr de~ ef~ots d~e ~t cl~.~ cour~e,~ do~ r ~pon~e ~voc un 4f~ It ~xl~l dQ
~klrn~l~tl~n. P~r ~irnpllflc~tlon, on d~ lnlt IJr,e unlt~ de 1~ st in;ll~t lon conune 14 do~3e d~ f ~ct2~r d cro~3~ nc~ qui, ~,~ out ~ n ~ r~ d~ u do e~ t ur~ ~ur d~r~
cell~ cLble~, ~st cop~blo d' indulrs n~ nug~n~cSlor, du no~,br~ df~ c~llule~ c~u d~ lnco~por~tlt I d~3 thymldln0 trlt11 ~ corre6por~ nt ~ molt1~ 0%) d~ ln v~l~ur r; m~3 ~ lm~ 3 dl3 Cl5 !~ u~t.~ nt~t lon m~jur~ ~na; 1~ ~ourb~ d,~s,~
r~pOI-~;3~ C~3ttQ ,i;!~flnl~lon ~t lo r~pr~c l~tlblllt~ d~ c~:~
m~sur~s .sont expo~ 3 notan~m~nt p~ Plc l~t ~t ~oll., ~n3 ~C~lIul~r ~nd Mole~ r Blology, ;~, p~ ,~ 5-I I0 (1994~)).
A1A~1~ plu3 1~ unl~ 3t m~ntenue ~ un v41~ur ~lbl~, plu3 f~c~eur con~r~ une ~c~iYlt~ blc>lo~ q~e lmport~nt,3.
A - ~ f~ k r~ ~ d ~ u c t l ~. d,1~:3 EF.~ .d~ t ~ !~
S~ ~ e t P~ ,n s .
. . .j l~n:~ c~: ~xp~rlence~, on utl 1~8 de~ Golutlonr~-m,`-res da F:GFo, c4ntennnt 1~ FGF~ ~n :~ ILlt~on ~ un~
onr r~t~ ~ r~ t l ~n ~ ~S~ p~ r rnl l l l l l t r~, ~lno un t ~mp,~n r!h~ p~l~ta lsotoniqu~ t~B~ t ~ont~n~ e ~u p~s ~u d~xtr~no ."l~l î dL ~ tDS) 1~. 63~;3 ~Ju cdtdlogu~ SI~ ~, Jl 400 J~ ml. 1.
dc1~ u ~a~lqu~ utlll ~ vr~t ~1'Q ~ n~ bovin6 et tr~lts du c~r~ de bo~ut, aclorl 1~ p~lblIc~t~on d~ Court~
~t uol l. IiQnJ ~BlvchlM1~, 69, p~$~ '~$I I ~ 87)~.
10 ,ul ~1~ c~t t C ~iol u~ lon sont pr~ v~s ~t nl~l4n~
.3~it ~ 1 ml ~ te-~pon ~EiS ~pH 7), ~ lt ~ C~
;J~kti~ll* ~4u¢n ~Ju~t~ 4 pH ~ ~nrlron iN~, ~olt b I ~
:~o~lt~ ~N;~O~ 11ul~*, ~3u.st~e ~ pll ~), G'. C~s ~ch4ntll1t)l~ s(~nt . j ;. ' ; ' ','' ~' ` ' ';
~"'' ''' ~ ,,' , ~ ;li, ~., :; ~;,;, ~ '~,",,",~"""
Z1, ~, ~,?~`.54 lncub~e ù 2~ 'C p~nd~nt 2 h~ure~ et un 1: ~ v~m~nt d~
e~t ~t'f~l-tu~ pour le dos~ge de l~actl~ ~ blolo~l~u~.
La f l~sure 1 pr~sel~te 1~ co~ b ~os~-r~pon ~ tu ~FI,~ s~r d~ flbrobl~te.Y d~ ~ertn~ hun7~ n .tA¢1523) nde de 1~ f~ r~ I
Ab6cl~3~es: do~es ~e f~ct~ur de cr l~s~n~e (p~/ml~
~r~onn~ polJrcent4~e d~ 3tl~ulo lon 1~ : bFCP ~ DS ~ pH 7 ~ : bFGF ~ p~ 7 V : bF 5F ~ ~S ~ p~ ~
A~. ; b~OF ~ pH 9 o : bFGF I ~5 ~ p~l 2 : bFGr: ~ pl 1 2 .
~5 L' ~ugment~t~on ~' incorpor~tlo d~ thym~tlr~e tr~t~ r~pré~ent~ 1~ v~leur du nombre 9 eoupo p~r mlnute ~cprn~ obt~nue au plate~u de 1~ ceurbo d *~-r~pon~e ~u ~I:G~' selll m~lns la v~ r en epln ds thymld~ trlt~ lncorporee don6 le,3 cellule~ en ~b:~-an::e ~e FG~ et ~rmlné~ d~n3 l~
~) m~me eXp~riqnee~
Le T~ble~u l r~3ume 1~$ r~Ssull ~t8 obt~nlJ~ ~ve~
al:~t' ~t bt'GF, L' unlt~i de ~tlmulation ~ t ai~bltralr~ment dorIn~ ~ L pour 1~ 4~GI: ou le bF~F ~o c~d p~rt ln~ub~ pendont 2 ~ur~3 ~ Z~ . . . .
Tqk~
_____ ~ _____._____~___ ____________~_ ~
~_____.___.___ ___ bl;'~F ~O'C) . 9 ~1:0~ (2 ~ 0-~) S:~ 13 3~ b~qF ~ DS ~2 Ii, 20 ~) 1 ~, 5 ~FCr~
o~'OI;' ~ ) ' C ) ~ G
cl'OI~ + C~S ~2 I~, 2~)'C) ~, 5 , ~ 2 ~ _ ~
:~5 ',. , I,-i., , . , . .. : ~ , ' '. ' , . : , , ~. : '.' ,' ! . : ' ' . .
'. , :; ' , , . ' ', , ' ' ' ' ' I , ' ', , ! ' :
', Z7)~ ' {~ - Etf.~t !~ ;t~n/~ f~te !!~ ~
p. ,~ u r e ~.t~i~ ~ ~ h~ ,C~' Dat)3 c~t t ~ p~rlenc6~, le ~0 pr~p~re Comm~ ~u poi.nt A ci-~e~slls, pour la forrne ~cid~, at pÆr~ recctmb~ ;on ~r~tlque pour la form~ ba~iquçl d' orl~ In~ hu~ln~, ~chet~
~upr~ de 1~ 5~clét~ A~n,~rs~hsn~ ~u Cllnl ~c~nc~ ~ P,~rl~), C'S4 Lncub~ b 4'C, ~) C, 37'C ou ~O'C p~ ~d~nt d~ érent~s p~rloul~s, en 1' Qb~C~ ou en pr~:~enc0 c ~ ~,00 ,l~z; ~e d~xtr.~ns u~. f ~ t ~, p~ d~ D~.
~L~
_~ _~__________-_____,_______________ ~ 3 ~ r ~ pr ~ nt ~ e por d ~ u: c br4n ~ he ~ 3 pr ~ nclpal ~ ~:
L ~ premi ~ r br ~ nch ~ t ~ d ~ C It- ~ ousl l ~ fi names de F&F bQsiq ~, de f ~ ct ~ ur de Cr ~ Oi ~ S ~ nCQ b oiqu ~ Ou d- typ ~ 2 a ~ n po ~ rl ~ h ~ p4rln ~ or ~ 3porln ~ ind ~ ~ O ~ c ~ th l ~ octoro (~ UCI: II), dG! f ~ ctel ~ rd ~ ~ rol ~ nc-3 çl ~ rv ~ du ~ rvotau or 3.5 ~ r ~ ln ~ lv ~ sd Crowth ~ actor II 5 ~ FX ~, d ~ ~ nct ~ 3ut ~ de crol ~ G ~ nce d ~ rlv ~ from o ~ ll or E; re-D ~ l ~ Ct ~ owth ~ tor I
,, . . . . . ... . . . . . . .
Z ~ S ~ l i '~ T' ~ 3 P ac te ~ lr c ~ ec roi ~ nc ~ d ~ 3 ~ tr ~ Cyt o ~ IX
A ~ F II, d ~ fnctel ~ r de croiS ~ nCe d4rlv ~ ~ u co ~ ei1 tc., DI o ~ u ~ lo deux ~ ab 4r.che cl ~ t om1 1 1 ~ 0 ~ t ~ d ~ crlt ~ sou ~ the names $ tle FCF ~ 1'd ~ or f ~ ctc \ Jr 'j af f ln po ~ lr hepar1ne do ~ ype I Ha ~; FI, f ~ ctour d ~ rlv ~ du cerve ~ u or B ~ OF X, fc ~ ctour de crolu ~ nl; ~ d ~ rive d ~ 1 'o ~ ll or E ~) CI; II, ~ ef ~ ctollr d ~ crol ~ s: 3rln ~ lo I ~ $ trocytc ~ u ACF I, f ~ ct ~ ur de cro ~ nco d ~ rlv ~ u cart ~ lnEse ~ CDCF I), etc. A tlt ~ er ~ r ~ nc ~ b bllo ~ r ~ phiqu ~
concerned ~ t the ~ cruiser ~ 3 ~ nce, n ~ lt ~ r4 y RLobb, d ~ o ~ 3 ~ An ~ lytic ~ l Bloch ~ mLo .ry ~ a4 ~ Ig ~> o, and J. Courty ~ t coll, dc ~ n ~ ~ h ~ m ~ Blophy ~. Re ~.
Comtnu ~ 10 ~ -10 ~ ~ 98G ~.
These ~ u ~ taur ~ ort therefore and ~ norn ~ o, or solon the ~ yp ~ d ~ cell ~ clble $ utili ~ s ~ f ~ ct ur3 cl ~ ~ oio ~ nc: ~
dc: s fiDrobl ~ 3t ~ trocyt ~ s ou ~ llule endoth ~, eve ~
lq3 ~ lgll93 r ~ pe ~ tlvem ~ nt FCF, AC ~, ECO ~, oo ~ t 5elon lo . ~ OI, II ~ C ~ 3 d 'o ~ ce fuct ~ ur ~: ~ t extrQit ~ p ~ re ~ compl ~, f ~ ct ~ ur d ~
croi ~ ce d ~ r ~ v0 du cerv ~ u, t ~ d ~ 1 ~ r ~ ln ~ s ~ ud ~: 3 ) yeu ~ o ~ l-til ~ 3, h ~ p ~ tocyt ~ in cu ture, ~ lc;
s1 ~ 1eo r ~ _: 3p ~ ctlv6 ~ ment B ~ ..F, RClCF, Ft ~ P ', C3GE ~, HI ~ GF, ~: t ~. ).
s ~ lt still ~ ~ ulon un ~ proprl ~ t ~ b ~ o ~ him c ~ u ~ ou b ~ olo ~; Lque (factor, ~ ~ c ~ ol ~ u ~ ce ~ f ~ p ~ ulr 1I h porl ~ 0 ~ ~ u î nct ~ r tumor ~ l ~ n ~; lo ~ nlq ~ R ~ TI ~ ~ au; c prin ~: lp ~ r, ,: 'i- ~ br ~ ncl-e ~ d ~ l ~ t ~ emllle l ~ tAllt ~ lor ~ nomn ~ lon co ~ æl ~ lo ~:
pr ~ c ~ s or 3ulvls d ~ l ~ mentis ~ n ~ 4c1dl ~ ou ~ b ~ iquQ--, or: lo m ~ ntlon l ~ typ ~ - or ntyps II ~.
C '~: 3t ~ n ~ llv ~ nt l ~ t ~ ~ lt ~ bo ~ oE ~ u ~ ~ ur de ~
C ~ llu ~ n cultl.lre qu ~ ee ~ f ~ ct ~ ur ~ on pll ~ tr ~ ap ~ rlf ~
L ~ prem1 ~ r ~ cor ~ ct ~ rLot ~ qu ~ phy ~ l ~ o- hlmique ~ ~ poldo n ~ ol ~ eulolre et point l ~ o ~ lectr ~ qu ~) orlt ~ t ~ 6 pub ~ sp ~ r Co ~ ipocl ~ rowlcz,, r, Biol. Chem. ~ EQ. 2 ~ lY C147Y ~ po ~ Jr ln ~ orm ~ 3 b ~ 3Lqu, 3 ,. ~ tp ~ r ~ i ~ rrlt ~ ult et al., J. N ~ 3uroscl. I9L 47 ~ 0 (19 ~ z> for lcl form ~ ~ c1de.
; ~ '. ,.
'~. .
,.
'. , ~; '~''' ~ "''` "''":
'''''''' j ''. '.
~ - Zil ~ r ~ 5 ~ l l ~ o purificntlon ~ homog ~ n ~ lt ~ ~ e ~ d ~ UK fqrm ~ u r ~ l ~ permi ~ ~ 'ét ~ bllr l ~ urs ~ tructure0 prlmolre ~; E. ~ ch r :, ~ t.-oll., Pro ~. Notl. f \ c ~ d. Sc ~. I.JS, ~ ~ !! S07 ~ 15B ~), p ~ u ~
1 ~ ferln ~ n 4 ~ 1qu ~ a, e ~ Oirnenez GÇ ~ SO and C411., 5clonc ~
l ~ 85 ~ l'385), po ~ r the form ~ c1 ~ 3. L ~ lsol ~ men ~ di ~ ls d ~ x forrn ~ t ~ ~ r, ~ ndement felvorl ~! por la dlSeouv ~ cte ~ 'un ~
forte nfflnlt ~ de C06 ~ fscteur ~ pour 1 '. h pel ~ ln ~ ~ t 1 'ut 11 i ~ aS lon subsé ~ uent ed' un ~ chrc ~ at ~ r ~ phl ~ d '~ f lnl t Gur h ~ parine lrnlmoblll ~ e (Shlng et al, Scl ~ nc ~,. ~, 1b 1296 ~ 9 ~ 1984)).
In v ~ tro, le33 FOF ~ ~ ont cnp ~ be ~ ~ e ~ ln prol ~ f ~ rntion ~ t 1 ~ dlff ~ r ~ nci ~ tlon d 'u gr4nd nonlbr ~ ~ e celll ~ lo ~ 3 prov ~ R ~ nt ds tl ~ sus ~ te ~ p ~ c ~: ~ dlff ~ rent ~. ~ n c ~ tcr4 cells ~ flbrobl ~ .stlques, en oth ~
15 ~ plt ~ la. ~ Sk ~ r ~ tlno ~ yte3, ehondr ~ y ~ o, myo ~ l ~
~ stro ~ 5 ~ tq3, ~ t ~ n ~ n ~ lera ~ g ~ n 10 ~ Ole d ~ FGr :: ~
d, 3n.s 1. ~ neuron ~ survival. In v ~ ~ rc ?. 1 ~ property ~ D
ncurotroph ~ ue3, anE5lo ~ enique: P ~ t Si ~ loonte ~ dr ~ FC; Fs ol ~ t c ~ n; qnt ~ t ~ d ~ shown ~ - ~ sd ~ r \ s of NUM ~ Ix ~ yot ~ m ~
XO L ~ r ~ l ~, dqn ~ la Yttlmlll4tlon ~ 1 ~ cl ~ oL ~ 9d ~ d.
1 ~ pid ~ trms, of an EXTRE ~ it ~ qu ~ ux de r ~ tl ~ p4rtl ~ m ~ nt purifl, ~ and therefore contain FGF comm0 ~ lnclpe nctlf, e- ~ t indlqu ~ d ~ ns 1 ~ br ~ vqt fr ~ n ~ 3 n ~ 2 4 ~, OO ~. L ~ r ~ e C ~ ~
same ~ :: very 5U ~ cicutrls ~ tion of ~ pl h ~ llum d ~ c ~ ln * ~ ~ t ~ 5 indl ~ ué à ~ n ~ le brev ~ t ~ m ~ ric ~ ln n '4 ~ ~ 7 435. ~ pul ~ ic ~
of no ~ rellx br ~ v ~ ts were ~ d ~ llvr ~ d ~ norn ~ r ~ u ~ ce ~ -publlc ~ tiono s ~ lentl ~ lque ~ ~ 3nt poru, ~ u ~ r ~ nt lo r ~ l ~ d ~: 3 I ~ Crs purlflé ~; t ~ n ~ 3 la r ~ nérc ~ lon ~ t 1 ~ le ~ eh ~ rl3 ~ ion of 1 ~:.
p * ~ u, dl_ $ V ~ iS ~ x, de, sr, erF ~, d2 ~ 4 09, d- ~ muscls: ~, ctc.
Most ~ rt: 1 ~ c ~; 3 trav ~ ux r ~ ult ~ nt d * 4 tron ~ pa ~ tlon de ~
obsarvot ian: ~ o ~ t3ur outfits ~ sc ~ lluli ~ s ~ n eulture ~ u; ~ m ~ m ~ 4 1 U l ~ v ~ ~ c7, / ~ ln ~ l, 1 '~ ppl ~ ~ ation ~ op ~ quo ~ ~ 3F ~ ul or 1 'utlli. ~ Atlon d ~ polyln ~ r ~, t' ~ pon ~, o ~ 1A OR ~ e pl ~ mp ~: ~
, 35 p ~ rmett ~ nt l ~ nr ~ larg ~ t de3 FGF ~, ~ Ut lnduiro urla n ~ oan ~ rl o $ ~ n ~ se ~ t url ~ r ~ n4r ~ t lon n ~ ~ U ~ or cut ~ n ~ e.
,:. . . ,:. : ~
''; , '~ ,,:''' ~ ' ','',.'''''''' .., '. '. ~: '' 2 ~
'.
~ hang, 1 'nppllcot lon topl ~ o from FGI: ocid ~ o ~
l) ~, l ~ u ~ olt: ~ o ~ nt ~ tr- ~ lt ~ r ~ t'Lve pol obter ~ lr 1 ~ cffet ~
mQ: clm ~ l.Jx. C ~ cl 6: 3t probably dC ~ 4 u ~ e, ln ~ obll ~ t ~
ther ~ n ~ qll. ~ of 1 ~ rnol ~ c ~ le, a proteolyr p ~ r dlæ3 in ~ ym ~ 4.
! ~ ~ lnsl qul ~ IJn ~ lnteract ~ n ~ ntre le ~ FO c et 1 ~ lyco4mlno-zlycones, col ~ une 1 'h ~ p ~ r ~ ae sulfate ou p ot ~ oh ~ r ~ n ~
sulf ~ t ~, de9 meml ~ relne ~ eellulslri ~ a or ~ ~ mambr ~ ne ~ 3 balcQle ~, e ~ r ~ fn ~ nt une lmmoblll ~ tlan de ~ a F ~ F ~ c.uvant emp ~ cher leur acc ~ ~ ux r ~ eepteur ~ e ~ llul ~ ro ~. At c ~ propo8, a ~ ~ b4ence ~ e 3tlm ~ Jlotlon de l ~ cl ~ z ~ tri ~ tlon p ~ r ~ FGF d ~ p2, ~ 1e ~
profon ~ -3 ~ ~ t ~ r ~ pport * e (J. D ~ rm ~ tol. 5urg. Oncol. t ;, 6 l 7-~ 25 ~ 19 ~ 6 ~) lor ~ that the Fap s ~ ul ~ t elpp ~ qu ~ a m ~ nlbrq toplqu ~, ~ when ur.e pr ~ l ~ f ~ r ~ tton fl ~ o ~ lu3t ~ q ~ ~ t ~ yobl4s ~, lqu6 ~ t obtainedR lor ~ qu ~ de ~ ep n ~ eonst ~ killed ~
1! ~ D '~ lc ~ ol polyvlnylique l ~ nbib ~ ~ e ~ GF ~ ot oppllqu ~ sou ~ 1 paau (J. ~ lol., 1 ~ 0, 12 ~ 9 C1985).
We ec ~ nst ~ te p ~ r ~ llleure qu ~ ~ FCF, ~ u ~ ol b ~ n in ~ form ~ cl ~ F ~; F) ~ u ~ ~ OU5 ~ 9 ~ elm bz ~; lque ~
~ eu 1 'we keep ~ 3 h ~ bltuelle ~ m ~ nt ~ -80', p ~ r ~ d- ~ J ~;
ctivite lor ~ que 11 e3t ~ m ~ né t. -20 '~ co ~ ~ templ ~ r ~ tur- ~
bi.3rlr, ~.
~ 1 ~ pp ~ r ~ it therefore 1 ~ c ~ 31t ~ d ~ 3t ~ blll; ~ 3r 1 f ~ cteul- ~ ds cro ~ s ~ 4nc ~ F ~ 3 ~ for p ~ uvo ~ ~ nvls ~ ser r ~ mont their ;, ~ pplle ~ tiorl: s. For the ~ ppllent ~ no ~ n vf ~ o L'5 notllmtnent, 1 s ~ r ~ lt avt ~ nt ~ eu ;; qu ~ ~ odG ~ d ~ ~ t ~ t lon the ulese will allow a relc of P; ~, Cl3 d ~ rn ~ qr ~ even ~ nt un aE ~ 3nt mito ~; ~ ne loco.l, r ~ ntr ~ nt d4n ~ le8 proces ~ on ~ turq ~ l ~ d ~ r ~ n ~ r ~ tion c ~ ll lult ~.
t ~ 1 'hol ~ te ~ ctu ~, compte t ~ ~ ud ~ 1' lmpc ~ rt ~ nc ~
d ~ G fnct ~ urs de cro1 ~ s ~ n ~ e dor ~ s lo ~ do ~ iln- ~ pr ~ c ~ eé3, on ~ lt q ~ c baAucoup d ~ t ~ nt ~ lb ~ ve: ~ ~ ont ~ f ~ ctu ~ a pour 3t ~ blll ~ rl ~ CFs, m ~ eonn ~ l ~ ~ nc ~ 3 la D ~ ent ~ 3, there ~ pQs ~ ncoro eLI ~ c ~ o ~ r dl3 propo ~ tion conclude ~ t ~ ~ t 4 ~ t1 ~ fo1 ~ nnt ~ for ~ t ~ b1114 ~ rl ~ o ~ for : 3'j que 113 con ~ e ~ -v ~ nt l ~ ur ~ ct1vitS r.on ~ - L ~ nt ~ n ~ ro, mol ~ 3 , s ~ m, ~ nt ln vi vo.
. ~. :. . . ... . .
. . . . ,,: ~,. ,::
:, '. , '~.' . ::
,. , ', :. . . , ~. ::
. ,,. rr , 'Zi3 ~
L, ~ presents ~ ~ u ~ wind lon ~ ppor ~, as for ~, a ~
t lon ~ u pr. ~ b ~ oY. ~, cor ~ t ~ nt ~ eoc ~, on un ~ tr, :) n.
., ~ ulr ~ J ~. ~ aux F ~ i ~ s, 1 ~ con ~ itlc ~ nr ~ ~ r ~ t ~ ~ t ~ nt etclbla ~ u ~ to ~ M ~ mæ ~ temp ~ r ~ tur ~ nbl ~ nte.
L ~ pr ~ nt ~ lnventlon ~ ~ onc pqu ~ obJ ~ t a ~ o ~ npo ~ lti ~ n co ~ npren ~ nt 1 '~ 3. ~ 0clot ~ L nd' ~ u molns a rorme ~ ctlv ~ ~ 'un ~ cteur d ~ c ~ ol ~ 4n ~ d ~ la ~ ml ~ l ~ FGF ~ t d '31- moin. ~ un ~ extr ~ n ~ eul r ate st ~ blll orlt 1' ~ Ctlv ~ t ~
blelo ~; ic of FC; F.
1 ~) Le ~ de: ct r ~ n ~ s 6ul f ~ tes ut ill ~ ~ have d ~ 3xt r ~ n ~ e . ~ ulfat ~ .P t, y: lr4 ~ 0lub ~, $ n401uble! ~ cn i ~ lou o ~ u ~ ux olJ r ~ -l3 In- '~ 3 IJ ~
L ~ tr ~ r, ~; t; ulf ~ te4 ~ ~ lub oer qu-t 1 'oo can ~ It ~ llsal- p4ur 1 ~ mi: 3 ~ en 02uvre ~ e 1 '~ Yon ~ lon, ~ nt do ~
1 ~ p, r, ~ uits ~ olJr ~ nt ~, or ~ ~ a r ~ i-r4:; ~ nt ~ p ~ r 1 ~ forrr, ul ~:
1 C ~ l ~. ~
~ n 0 ~ '.
d ~ n ~ u * lls u ~ h trols ~ roupe: ~ hydro yl ~ du n ~ Ot ~ r ~ onom. ~ re s ~ "lt ~ t 1 t U \ ~! ~; p ~ r cle. ,, ~ roup ~ -0-503 ~ forme ~ ld ~) 0 .5 - C ~ - .; f ~ (f ~ r ~; le ~. Le :; produl ~ s oo plus ~ u ~., Ont d ~. ~ p ~ lt. ~ l ~ $ sou ~ 3 forn ~ ad ~: ~ el: sd ~ ~ odl ~
L ~ 3: 3 products pr ~ f ~ r ~ p ~ Uv ~ n ~ tr ~ o polyn ~ br ~ 3 ~ e ~ n ~, tA M ~ cul ~ lr ~ cQmpr ~ se ~ nt ~ ^ e 1 ~ 000 ~ ~ 00 I ~ O, nt. ~ ntnt nt, 2r ~ tr ~. ~ 000 and 5VO 00 ~, tol3 ql, l ~ 1 'on p ~ ut e.' ~ n . ~) præc ~ kr ~ up ~ d ~ 1 ~ Socl ~ t ~ ~ ICMA ~ R t` ~ 07 ~, Dl ~ 39 ~, ~ OC ~ 7 l 40, ~ 3 ~ 06 of the cPt e ~ u ~ l9 ~ S ~).
L ~ 3 ~ xtran ~ ulfAto ~ lnfi ~ c ~ l bla ~ 40nt ~, e d ~: ~ tranæ ~ l3cul ~ t0 ~ r ~ tl ~ ul ~ e according to 13i ~ proc ~ d ~! ~ h4bltu ~ 13 ~ e ~ t ~ 3., ~ t, i ~ n, cn portleull ~ r ~ ld ~ '~ pLchlol ~ hydrlnk,; ~ r ~ 5.
.., ... ; ',. ,,. ':'',.',''.''.'':.''' ~. thp ~, C ~ I IX ~; l C! rl ~ r mu ~
Q
~ 1 ~ O ~ CH
OH, ~ O
~ H ~ O - d 2 ; 1 :! --O ~
CH-OH ~) ~ 1 ~ - o OH
;:
1_1 HO ~ 1 \
O - CH ~ o> ~ 2:
~ 2 ~ \ -o 1 1 ~ 0 ~! ~ C) ~ ~ ........ 1 0 ~ 1 ow ~ s l. ~ c ~ un ~ ~ r ~ on ~ s group ~: ~ hydl-o ~ yl, 2, ~ ~, t ; . ub ~ t 1 tl ~ S ~ by d ~, r ~ up ~ 0-503H or 0-50; 11 ~ p ~ erlt 5 ~! pr ~ ~ nt ~ r ~ or ~ form ~ d ~ poudr ~ or e ~ el ~.
Colr, me ex ~ pl ~ cl- ~ e ~ E: d ~ xtrnr ~ ~ ~ ulf ~ to3 ~ on p ~ l ~ t clt ~ rc, ~ lui commercl ~ p ~ r 1 ~ ScelA 6 51 ~ oU ~ 1 r ~ r r. ~ r ~ tal ~ u ~ 19. '' tt ~ np ~ Ut ~ 41 ~ nt o ~ e ~
tf ~ l: ad ~ 3; ~ tr ~ nH ~ ~ e1 on lf ~ p ~ otc ~ colel d ~ rtp ~ Mll ~ t ld. ~ J. ~ t cctll, An ~ l. Blt.?ch8~n. .LQ. ~ -: 304 ~ 0).
~ \ u ~ ln t ~ eompa ~ iltlon ~ on 1 'lnv ~ ntl ~ n, 1 ~ .3 tr ct r \ t ~ lJ lf 4 t es hy P ro ~ olu ~ on t ~ nts ~ un ~
~ ollc ~ ntr ~ tlc? n dta ~ FO m, ~ p ~ rm ~ 1111tro d ~ m ~ l4r "7.4 n ~ 3l. L ~ ~ nc, ¢ rltrat1on ~ o ~ ~ xtr4r ~; t ~ ulf ~ tfa ~ 3 ln ~ all bl.
: i ~ n ~., m ~ lf ~ t ~ t ~ Rxtrant ~ s ~ tF ~ $ p ~ ut 11 ~, ~ ~ æ
, ~ lJ:,; t - ', l, ~' a 50C ~ m ~ F ~ m ~ 1 llllt ro ou 2 r ~ ~ de n ~ n ~ rln ~ l.
',.
. ~
,,;,, j ",, i,.
';''',:'"~'"'' 2 ~; ~ r ~ 5 ~
,.
1. ~ eompo ~ ltlon s ~ lon 1 '~ nvent on contlenS p ~ r aill ~ ur. ~ ~ vanto ~ eusernellt des qu ~ ntlt ~ a; ~ fsct ~ true ~ O, ~ 1 rg 3 ~ 0 Jl ~ t '~ u nlolns une forrn ~ ~ ctlve do F ~ p ~ r mlllllltre ~ u gr ~ mme de mblan ~; e final ~ F ~ dextr ~ no ~ fAt ~.
L ~ d ~ xtr ~ no ~ oul ~ e ~ te3 ut ~ ~ pour 1 ~ ml5c en o ~ uvro ~ prb ~ nt ~ lnv ~ nt ~ on ~ er ~ en ~ d ~ ~ upport b 1 ~
ml ~ r ~ tlon ~ t QU ropouplem ~ nt cel ~ ul ~ lr ~ They can ~ nt ~ tr ~:
lncorpor ~ s dan ~ tout ~ s form ~ do p ~ n ~ o ~ nt ~, or ~ ncorr on fll ~ of ~ uture used ~ s in chlrurE ~, d ~ me ~ nlbr ~ que 1 1 ~ fact ~ ur ~ 56aoci ~ ~ c ~ dextrcn ~ ~ ulf4t ~ o ~ f ~ ct ~ ur tout : only pui ~ lf ~ u ~ r Yer ~ los ti ~ u ~ ~ l 1 L ~ 3 ~ cteur: sd ~ c ~ olss ~ ncQ F ~ utl ~ d4n :; cett13 invention p ~ uv ~ nt be d ~ prodult4 n ~ rolo, ~ s prodult3 u :; d ~:; ynth ~ e ~ chl ~ iqlle. ~ ou dc3 pro ~ Lt ~ obt ~ nl ~ 3 p4r ~ e;: ~
I !; techniq ~ es ds recombln ~ l ~ on ~ tlq ~ lo. It ~ can ~ u ~ tr ~
to ol ~ lgine hum ~ lne or to come from A ~ tre3 ~ rn ~ lfere ~ t no n ~ m ~ lf ~ re: ~ s. I ln ~ t ~ en ~ r ~ ler ~ ent p ~ ~ e ~ aslr ~ d 'ut lll: 13r 1 ~ t '~ ct ~ r ~ utologu ~. In ~ f fet, 1 ~ hol ~ ~~ conse ~
v ~ tlon of 1 ~ ~ tructllrç of ~ 3 F ~ F ~; ~ u C ~ UF of f ~ olutlon, n! ~ 1 q, ~ Q ~ ~ t ~ lde ~ ur le! ~ prop ~ t ~ a ~ n ~ lero et in ~
ln, ~ lqu ~ l ~ t that lL y 'p ~ d ~ e sp ~ clflclt cl' ~ p ~ c ~ for the;. ~ ~
dc ~ for ~ lle3 blo ~ ctive ~ da: 3 ~ ril ~ E ~ l ~ nt, orl utlll ~ a 1 ~ 3 ~, t` ~ oua ~ for ~ n ~ purlfi ~ e ~ el ~ e, or ~ o ~ 30 ~ ~ orm.3 baalq ~ le, or a m ~ l4n ~; e dQ: 3 d ~ lux form ~, c I ~ 2neoro un ~ rl ~ 5 ~ U
; '~ un ~ n ~ loé5u ~ u mo ~ n ~ 1' un61 do ~ a ~ fo ~ ~, L ~ ropport ent rc ~ s PCF ~ 4clde and ~ n ~ l ~ uo d ~ n ~ ~, form ~ n ~ p ~ l ~ t Atr ~ d ~ n 'lmporto quQlle v ~ laur ~ ntt ~ 1 ~ daux for ~ e ~ pur ~, Dlff ~ ront ~ proc ~ d ~ 7 do purlf'l ~ lon pau ~ nt ~ tre utll ~ s ~ s for l ~ lar this ~ dcux f ~ rm ~ a ~ ad ~ CJP ~ p ~ rtlr d ~. -oour ~ n ~ turell ~ fi Cr ~ tlno. c ~ rv ~ u, h ~ ~ elphy ~, plqlc-3nt4, r ~ in, ~ tc. >, c ~ proc ~ t ~ nt eonn ~ 4 t. 4y ~ nt 4t ~ described.
by dc r ~ ombrollx ~ t0ur ~. LQ m ~ thod ~ pr ~ r2 ~ tc ~ llo déçrlto pe7r ~; or ~ ty ~ t ~ oll. d ~ ns; (~ Bloc1r ~ G7. Blophyiil, R ~ 3.
Commun.,, ~, 102-lOB ~ lg ~ m C ~ tto r ~ thod ~ compr ~ l7d un ~
~ 5 ~ topc ~ on ~ 3l ~ t ~ nt 0. trc ~ lt ~ r, pen ~ 4nt ~ n night, do l ~ xtr ~ lt t i61al.1 ~, 7n ~ pr ~: 3t7nc ~ d '~ elt ~ 7 ~ 1 ~ c ~ tL ~ ~ ~ p ~ t 3, o ~ ccl ~ lan ~
,!, ~ '. ; ,; 1 Z ~ 5 ~
~ n ~ l tout rl- ~ qu ~ d ~ ~ ontomlntlti ~ n vlral ~, ~ t ~ ~ ondulra IJne p ~ o-iflc ~ tion p ~ l ~ chrom ~ to ~ r ~ phie ~ ur h ~ 3rlne lmmob ~ e p ~ rlne ~ eph ~ ro. ~ HAR ~ 1ACI ~. Loo c ~ ix f ~ rm ~ oeLde ~ t b ~ slque d ~ FCF pe ~ vent Qln ~ l être 1 ~ o7 ~ q ~ ~ tf ~ par ~ 4s ~ nvec le. ~ 4utres prott ~ lnl ~ 8 OU lnd ~ vlduell ~ men, e3ve ~ un ~ b ~ r ~ d ~
plJ ~ and ~ suffl! 3 ~ lnt pour atre d ~ b4rras3 ~ e ~ o ~ u ~ ntlt ~ 5 *
~ lgn- ~ lcatlv ~ .sd 'autr ~ mdt ~ rl ~ l ~ con ~ ~ nelnt ~.
~ es ~ nalo ~ ue ~ ~ ynth ~ tf que ~ ~ u ~ 0 ~ p ~ uvent att ~ e obtained pnr synth ~ chlmiqu ~ or pnr ds t ~ chnlquo ~
cll333 ~ c3u ¢: ~ d '~ nz ~ nl2rle ~ n ~ tlqu3, t ~ ll 1' oxpr2! 4 ~ 0n: le g ~ r, ea synth ~ tiq ~ es or l ~ pr ~ slon ~ n ~ o mocl ~ fl ~ pcr t ~ z3-3 diri; ~ d ~ lte ~ ~ p ~ lq ~
To ~ lt ~ a 1 ~ formQ: ~ de FGF obt- u ~ nd '~ xtr ~ lt a tl ~ ul4irr ~ p ~ r in ~ eni ~ rl ~ nétlq ~ l ~ or p ~ r synth ~
cnlrnlque, qul ell ~: ~ 41ent or not ur ~ e ~ tr cture modlflée, ~ lr) sl qu ~ le ~ fr ~ gmenta en d ~ r ~ t, p ~ v ~ nt ~ ro ut11s ~ e ~
~ or- r ~ '~ aerYe que elle3 4 ~ o ~ ent ~ ctlve; l ~ bl log ~ uement - un te. ~ t ln vi ~ ro cl ~; nm ~ the one pr ~ po ~ cl-clp ~ p ~ w4nt etr ~
utlli ~, 2 ~ 3 as ~ ti on! I ~ of FOFc t ~ t 4 cl ~ x ~ r ~ 3 ~ s ~ .J lf ~ t d ~ nvellt ~ on p ~ u ~ nt ~ tne ~ ncorpor ~ e ~ dsn ~ d ~ Uppvrt ~
phy ~ 1o1o; 31 ~ uem ~ nt ~ c- ~ ptab1e ~ p ~ ur d ~ ppllc ~ t ~ on ~ ln v ~ v ~, pl1c ~ t1on ~ st une elppl ~ catlon loc41, p ~ vo1a e ;; tenno ~ ur 1 ~ pa ~ u or 1 ~ co ~ e, not ~ mm ~ nt pO ~ I ~ ~ cc ~ l ~ r ~ r 1 clcc ~ trl ~ s ~ t ~ on a ~ pltlie ~ t 4m ~} 110rsr ~ qu411t ~ do cett- ~
~ lcatri. ~ tion, or ~ ncc ~ re p ~ r v01 ~ 2 lnt ~ r ~ l ~ ur 1 ~ t or ~ n ~ 3 du oorp6 ~, p ~ r ~ x ~ mple d ~ no 1 ~ t ~ ltem ~ nt d ~ 1 'uLc ~ ro ds 1 '~ stom ~ ç. L ~ l ~ s ~ type ~ l! Tl ~ ud 'c ~ ppl lc ~ tlon, l ~ a coml ~ o ~ 1tion3 Compr ~ n ~ nt 1 '~ a ~ ocla ~ on ~ ~ F ~ F ~ ~ td ~
3 (~ d ~:; trnn ~ a oul ~ a ~ Q ~ ~ eront dlf f ~ r ~ nt ~.. 1 ~ n ~ lt ~ ro ~ d ~
3upport ~ p-3ut ~ trQ c ~ ctr ~ ont v ~ rl ~ bl at d4 ~ and ~ onc du typa at llcu d 'uppl ~ ccltion, ~ t prut pt ~ ~ Idr ~ la forln ~ Jn lit ~ uldl ~, a / i ~, '9s4 ~ un ~ cr ~ me, d'~ ~ ~ ol, ~ n tl ~ su ~ II) p ~ n ~ comn ~ o un ~ ~ o ~ o, tull ~ ~ oci ~ t ~ on: 3 ~ G ~ '3-d ~ xtr ~ neo ~ ulfnt ~ e ~ lnvention p ~ R ~ V ~ ~ ~ gal ~ n ~; ~ very ~
lncorpor ~ e ~ ~ un ~ tln ~ eon ~ tlSu ~ ~ r a collos ~ n ~, qu ~ l ., -. . . ~ - ~. ::.,,:
:.
z ~ z ~
that ~ n solk the typ ~, or ~ ncore, like Is ~ i ~ t Ci-d @ ~ 3, recou ~ n lr de ~ rlls de ~ utur ~
~ e3 forll ~ ulQtlons ~ qu ~ u, soR ~ '$ nv ~ rltlon 1; eront o ~ nt ~ eu: ~ erl ~ nt d ~ s conp ~ sitlon ~ conten rt d ~ t ~ mpons and salts allowing m ~ int ~ nlr 1 ~ m ~ l4ng ~ ~ u vol ~ ln ~ 'du pl ~
physlolog1 qu ~ et ~ u volslnc ~ de 1 ~ for q ~ lon ~ que ~
phy31c> 10s: 1 ~ eu ~ olt pH of 6, ~ t ~ 7, 4, ~ t foree lonlq, ue ~ O, 1 ~ 0.2M). We can ~ Joust ~ compolsl ~ OA dl ~ 8 ~ ddlt lf8, comrn ~ ~ e ~ nn ~ th ~ lqu ~ s loc ~ ux ~ p ~ r ~ x ~ pl ~ a lldoc ~ Ino) ~
d ~ o 6ub ~ 3t ~ nce b ~ ct4ric: ~ st ~ tick ~ ~ by e ~ pl ~, do ~ 6el ~ s de s ~ dlum, d 'l ~ rsent, 1QU ~ S d ~ rlY ~ a ~ o ~ t ~ Ol ~ tu ~ f4 ~ 1e3 ~ 1n ~ e ~ 3 produl ~ t ~ epti ~ nts, ~ comm ~ B ~ tad ~ n ~, deJ ~ n ~ lblotlq ~ t ~;
~ p ~ rc:; ~ m.ple, 1 ~ streptomyclne), ~ e ~ pr t ~ n ~ ~ t ~ que ~ ~ p ~ r ex ~ ple, ln ~ rum albumin ~ or l ~ flbron ctin ~, as well as from t coll ~ n ~ ta hydr ~ solubl ~.
A tall ~ cornposltion ~ qu ~ us ~ r ~ nf ~ rm ~ nt ~ u mo ~ rls a f ~ cteur ~ CF ~ ssocl ~ 9 a ~ l moln ~ a ~ tr ~ n ~ 6ulfate ~. -hy ~ ro ~ vluble or insoluble, p ~ ut ~ tr0 u ~ ll ~ o dlr ~ oct ~ n ~ qnt 0n solutl ~ n, 6tn 41 ~ ro5tol, ell onction, en lo lon, ~ n poud- ~ ou ~ n 591, OR ~ el ~ vlr d ~ ~; olution pour ~ tr ~ ln lus ~ don ~ urt:; upp ~ rt ph ~ r ~ nacel. ~ tlqu ~ ment or co: ~; rn ~ tl4u ~ 3m3nt. ac e ~ ptoble, t ~ l ~ tl '4n ~ 1 apple ~ ds, a ~ crbme, a ~ el de re ~ no ~ a ~ 1 of a ~ ~
aut r ~ n ~ t ur ~, or 1 ~ t lne or 1 ~ ~ regn ~ r un ~ e ~ olla ~ n ~, un ~ 'unq ~ utr ~ n ~ tUr ~, RI d' ~ other ~ ul ~ qt ~ n ~
~ 5 fol34nt ~ on ~ sponge tion, a pQna ~ e ~ m ~ nt a ~ uppore d ~
overlay or biom ~ at ~ key ~ vtlnt fn ~ orlsor dir ~ ct ~ m ~ nt or ~ ndlre ~ ement 1 ~ r ~ p ~ rA ~ ~ on tlo4iulalr2 tp ~ r ax ~ mpl ~, a fll of ~ ut ~ ro chlrur ~ Slc ~ l) or ~ l; ro ~ ppllqu ~
~ ur d0 ~ flbr ~ na ~ ur ~ lleo oU rynth ~ tlq ~ ~.
"~ O For d6! S oppli ~ t ~ or ~ r 1 ~ I ~ U, lo ~ ba ~ de cr ~ m ~ or lotlon ~ used ~ trcldltSonnq Llo ~ r3t p ~ uvent ~ tr ~
utlli4i6 ~ s, Comme 1 ~ l ~ nolina (Silv ~ d ~ n ~ ~ M ~ arlon plu: ~
by ~ t lcull ~ rl ~ mant pcur le! .5 bru ~, ~ sJ Aquql ~ or Puk ~ 2 L ~ bor4tor1 ~ 0 ~; o ~ th Norw41k, C: onn ~ ctleu, l ~ qu ~
~ Gold ~ l)). Leo ~ rbm ~: j peuv ~ nt cont ~ n ~ 0 prot ~ 1no ~ ~ p ~ r ~: ~ elnplc, ~ oll ~ n ~ tins2, ~ te. ).
,.
`` `z ~ 2S4 -.
L ~ p ~ ns ~ m ~ nt. can be from pono ~ mento cl ~
toxtll ~ .i, tls ~ u ~. ~ ynth ~ ticks or ~ pong ~, o ~ l ~ ttr ~ 3 ~ 3 protluits n ~ t ~ real s ~ rvant de r ~ blanket t of pl ~ Sp ~ r e ~ rnple, de3 ~ els de coll ~ ne, cleR del ~ e4 ~. orl ~ lne ~ ni7 ~ 1a), L ~ compos ~ .tion FGP`-doxtr ~ n ~ ulfot ~ on ~ olutlon do ~ t puolr lmpr ~ n ~ r these dlf ~ n ~ orma ~ d ~ pon) 3 ~ nts, de monl ~ re que le fQ ~ t ~ Jr F ~ F pul ~ t ~ on contaet ou dlf f ~ lser s ~ ul or e ~ 3 o-; ie c ~ ud ~ xtt- ~ n ~ 6u fat0 ~ squ 'nu: c tls ~ u ~ clbleo. L ~ co7npo91tlon ~ lon l ~ n ~ ntlon ~ 3t lo ~ ppl ~ qu ~ e ~ lem ~ nt de m ~ ni ~ ro ~ moyol ~ tr ~ ~ slnt4n ~ 0. ~ ur le ~ ite de 1 ~ bl ~ s ~ ure et: sur le ~ b ~ er ~ oo ~ l ~ art ~ Y ~
m ~ lntlen de 1 hyclr ~ tatlon ~ lon lo ~ ~ ee ngq ~ os ~ e 1 ~ ho ~ m ~ du profession, p ~ rt ~ u ~ l ~ rem ~ nt ~ l ~ bo ~ d ~ n ~ le dom ~ ln ~ d ~ s graft ~ ~ c ~ pe, ~ u. Ie:; p ~ næ ~ ment ~ ~ ec u ~ lf ~ peuvont ~ tro lr / ~ pr ~ n ~ d ~ 1A m- ~ m m niere, ~ dsorb ~ or recover a ~ upport n ~ t ul ~ el ou: 3ynth ~ t lqu2.
Pou ~ le ~ ~ ppllc ~ tlon ~ sur 1 ~ 0 cvrn ~ o, 1 ~ v ~ h ~ cule dvlt ~ trR compo.tlbl ~ av ~ t.ol ~ ranc ~ cul41re ~ on c ~ t6 ~ r ~
co ~ nrne ~ mp ~ of such a v ~ lllcul ~ pro ult commc ~ -cl ~
:; OR 3 the name of ~ L ~ er l bu le ~ J), le ~ t on ~ lln ~
solut iVI- lsotonlq ~ eu: 3 ~ p ~ l ~ e:; ~ mpl ~ 40c ~ dron ~ 1 ~ 1erc ~
5h ~ rp-Dohm ~) or ~ equivalent), or oro ~ or ~ form ~
gel forming a ~ notch ~ t ~ ct ~ ur d ~ 1A c rn ~. C ~ 3 v- ~ h ~ culo.s p ~ uv ~ nt cont ~ n ~ r ~ 3alomen ~ dw ~ e ont ~ cn ~ orv ~ t * ur ~ comn ~, ~
3;: hlorur ~ s ~ ben ~ yldim ~ thyl 41kyl ~ mol lu ~ or f ~ thyl ~ nQ
di ~ mine t ~ tr ~ ac ~ t ~ t ~ 3 dl: sodium ~ DTA).
It can é ~ ra ~ nt ~ r61 ~ ouh ~ 1 tlble d 'lnclur ~, ion ~
de ~ llposom ~, une ~ s ~ oclclt ~ on Ft; F-dox ~ An ~ 4Ulf ~ t ~
hy ~ rosolubl ~ dc 1 'lnv ~ ntlon. C ~ 3 llpo ~, n ~ mauve ~ t dtr ~
qlorEs lncorpor ~ d ~ ns le ~ compo ~ ltlono ~: rita: ~ cl ~ e ~ u, 3, p ~ r ~ x ~ rnpl ~, cr ~ m ~: a, pc) mm ~ d ~ o, utll ~ 3 ~, ~ llo ~ qu ~ s or for the iMp ~; n ~ tion d ~, ~ upport ~, ~ omm ~ ~: ~ pan ~ m ~ nt ~.
n ~ la c ~ i3 o ~ l 'ut ~ lloo d ~ d ~ ctr ~ neo ~ ulf ~ te :;
lni ~ ol ~ ~; les, '~ eu ~ -cl p ~ uvont ~ itro s1mpl ~ ~ nt a ~ o ~ i3 a or bicr ~ talleo 4 ~ 0clatloao p ~ uvont ~ ro lnelusoi3 ~ sb ~
deo i3upporti3, ~ omme d ~ cr ~ m ~, de ~ ~ 4J ~ tln ~ o ou d ~, 3 gel: 3 de . ~:, '''''''"''''''.
,, '' :. . .. ~:, '' ;. ,,: ~
; Z'lJ ~; ~ q.'D2 (5 collr. ~ z ~ s, ~ 1 ~ be ~ ppltgu, '~, s fii ~ fl ~ r ~ ~ ynth ~ tlqu ~
ou rlatu ~ e ~ ~ f ~ ls cl ~ clure ?, or l ~ iF ~ n ~ r ~ upp- ~ rts habl.u ~ ls ~ - ~ ep ~ n ~ e. ~ ent ~ recover ~ m ~ n. Lnclu ~ lcn de ~ s of: ~ tranes sulfata3 ln. ~ lubles peut ~ iQ ~ lro p ~ rl ~ blbltlon ~ / or ~ dc ~ lti ~ nd ~ un ~: solutlon de coll ~ e ~ n ~ ~ t ~ llfl ~ ~ tLon.
On p;: ut notamm ~ nt ~! Ti ~ l ~ er le ~ ot ~ 3 op ~ e ~ t31re d ~ crlt 4 ~ n ~; the tre- ~ t U5-A-4 0 ~ 0 0. ~; u ~ v4nt lsquel nr ~ llse ~ In ~
co ~ nposltion ~, t ~ lflé * ~ omp ~ slt ~ d ~ ns ~ u ~ llo l ~ p ~ rtl ~ an CC`t ') tACt nvec la ble ~ ure a ~ t ~ ~ coll ~ n ~ r ~ tlcul ~
~ 0 ~ \ Vf ~ n ~ lyco ~ mln ~ gly ~ n ~ SI ~ n ~ 4tant o ~ teflu par , ~ d 1.11 t 1 on d ud 1 tgl yc oo ~ ~ 1 no ~ 1 ye anh ~ uc 1 1 Qs ~ n ~ ~ Oa ub ~ nslhmbl ~ ~ both pr ~ Iplt ~ or r ~ t1cul ~ p ~ t ~ du ~ lut ~. ~ rolddhydt ~. '' By 0111 ~, co ~ nme ~ ndlqu ~ ~ -dos ~ ll3 ~ le: ~
;! ~ C ~! RlpO ~ n ~: 3 ~ 1 ~ n 1 'In ~ nt1on p ~ uv ~ nt ~; 3ol ~ 9e ~ t p ~,: s. ~ nt,: l ~ 4u ~ un ~ f ~ r ~ e appl $ cable lc ~ letn ~ nt p ~ r ~ ol ~
Interr *, for example c ~. ~ M ~ pl ~ tr ~, n ~ 4tro-ont ~ rlqu ~ 6 cu pO ~ b ~; lyophll15 ~ .ea ~ nclusas ~ u nan d no das z ~ lule3.
LA pr ~ pdr ~ tlon de ~ co ~ po ~ ltl ns de tr ~ lt ~ merlt, ~
ic, ~ trl. ~ 4t ~ 0n: 3e10n Ll LnV ~ rlt10n ~: 3t, d Un ~ ~ n ~ g ~ n ~ r41 ~, r ~ e ~ elon de3 m ~ thodQra cla: 3 ~.; lqu ~ blan co ~ nu ~ 3 ~ n nl4u ~ e. L ~: ~ dos ~ $ ~ ~ d ~ nlnl ~ tre ~ ol ~ ur fr ~ ql ~ ence .sont or1 ~ 3 not ~ mtner ~ t: se10n 11ImpDrt ~ t. ~ d ~ l ~ pl ~ lC.
Enflrll ~ COi ~ tpOi31t10lll ~ 5 ~ 310 ~, 'ln ~ / entLon kl ~ or. ~ Ent lert ~ ent, 3pplic ~ t lot ~ t dah ~ l ~ dom ~ lno o ~ m ~ tl ~ ue, for ~ m ~ IIor ~ r ~ t4t d ~ l ~ p ~ au. Ln ~ ttnt on ~ nc ~ o ~ m ~ n ~ s ~ mpo3 ~ tlon ~ co ~ t ~ tn ~ nt, n ~ un ~ uppt ~ t cosm- ~ tlq ~ emerlt ~ c ~ lpt ~, une a6 ~ io ~; 14 lon pr ~ clt ~ FCF--tran ~ ~ ultat ~ :, c ~ tte c ~ poGlt ~ on s ~ pr ~ s ~ rltAnt not ~ mrnent, i ~; form ~ key ~ tlor, ~ al or cr ~ t. .. ....
We ~ crlr ~ molnt ~ nortt l ~; ~ of ~ t ~ d ~ d ~ tl- ~ tn ~
6ulr ~ t ~ UI ~ prot ~ ct ~ ot ~ 3 1 '~ itl ~ l ~ t bLolo ~ l ~ ue d ~ 3 rt ~;.
L ~ h, ~ v ~ lu ~ n ~ 1 Y ~ t ~ ctl - ~ t - ~
h ~ ue l ~ 'CF3 s ~ 2nt d4c ~ 1te, 3 d4n ~ dc no ~ nbreuo ~.
~ IL> lic. ~ Tlor ~ t ~ lle.3 ~ have everything ~ ba- ~ olt ~ r un ', ,,', '",'. i '' .1,,, ' Z ~
l ~
m ~ .lsuro (.! el 'b ~ lgrrlent4t l4n, lu n ~ br ~ da C l ~ u1 ~ 3 ~ nd ~ p4 rl ~ :, d- ~ ..e :, crol3is4nte ~ C1 ~ 3 farteur6 4 ~ 10ut 4 ~ u ~ place of cultl ~ r ~ d ~ llule ~, ~ olt ~ ur un ~ 'nt ~ t ~ on do 1 'lnl: orpo ~ tlon de thymldine t ~ ltl ~ ed ~ ~ DIl de ~ cellul ~ J
3t Irnul ~ r: ~ 3 p ~ r lr ~ f ~ cte ~ rd ~ crol6 $ ~ ne ~. D ~ ns 1 ~ u: c protocolc, these ~ u ~ ent ~ tl ~ n ~ on ~ d ~ p ~, d ~ nt ~ de 1 ~ d ~ d ~
f ~ ct ~ ur ~ jo-lté ~, ~ t 1 'we can ~ unc et4t Lr de ~ ef ~ ots d ~ e ~ t cl ~. ~ cour ~ e, ~ do ~ r ~ pon ~ e ~ voc un 4f ~ It ~ xl ~ l dQ
~ klrn ~ l ~ tl ~ n. P ~ r ~ irnpllflc ~ tlon, on d ~ lnlt IJr, e unlt ~ de 1 ~ st in; ll ~ t lon conune 14 do ~ 3e d ~ f ~ ct2 ~ rd cro ~ 3 ~ nc ~ qui, ~, ~ out ~ n ~ r ~ d ~ u do e ~ t ur ~ ~ ur d ~ r ~
cell ~ cLble ~, ~ st cop ~ blo d 'indulrs n ~ nug ~ n ~ cSlor, du no ~, br ~ df ~ c ~ llule ~ c ~ ud ~ lnco ~ por ~ tlt I d ~ 3 thymldln0 trlt11 ~ corre6por ~ nt ~ molt1 ~ 0%) d ~ ln v ~ l ~ ur r; m ~ 3 ~ lm ~ 3 dl3 Cl5! ~ u ~ t. ~ nt ~ t lon m ~ jur ~ ~ na; 1 ~ ~ ourb ~ d, ~ s, ~
r ~ pOI- ~; 3 ~ C ~ 3ttQ, i;! ~ flnl ~ lon ~ t lo r ~ pr ~ cl ~ tlblllt ~ d ~ c ~: ~
m ~ sur ~ s .ont expo ~ 3 notan ~ m ~ nt p ~ Plc l ~ t ~ t ~ oll., ~ n3 ~ C ~ lIul ~ r ~ nd Mole ~ r Blology,; ~, p ~, ~ 5-I I0 (1994 ~)).
A1A ~ 1 ~ plu3 1 ~ unl ~ 3t m ~ ntenue ~ un v41 ~ ur ~ lbl ~, plu3 f ~ c ~ eur con ~ r ~ une ~ c ~ iYlt ~ blc> lo ~ q ~ e lmport ~ nt, 3.
A - ~ f ~ kr ~ ~ d ~ u ctl ~. d, 1 ~: 3 EF. ~ .d ~ t ~! ~
S ~ ~ and P ~, ns.
. . .j l ~ n: ~ c ~: ~ xp ~ rlence ~, we use 1 ~ 8 of ~ Golutlonr ~ -m, `-res da F: GFo, c4ntennnt 1 ~ FGF ~ ~ n: ~ ILlt ~ on ~ un ~
onr r ~ t ~ ~ r ~ tl ~ n ~ ~ S ~ p ~ r rnl llllltr ~, ~ lno un t ~ mp, ~ n r! h ~ p ~ l ~ ta lsotoniqu ~ t ~ B ~ t ~ ont ~ n ~ e ~ up ~ s ~ ud ~ xtr ~ no . "l ~ l î dL ~ tDS) 1 ~. 63 ~; 3 ~ Ju cdtdlogu ~ SI ~ ~, Jl 400 J ~ ml. 1.
dc1 ~ u ~ a ~ lqu ~ utlll ~ vr ~ t ~ 1'Q ~ n ~ bovin6 et tr ~ lts du c ~ r ~ de bo ~ ut, aclorl 1 ~ p ~ lblIc ~ t ~ on d ~ Court ~
~ u u l. IiQnJ ~ BlvchlM1 ~, 69, p ~ $ ~ '~ $ II ~ 87) ~.
10, ul ~ 1 ~ c ~ tt C ~ iol u ~ lon are pr ~ v ~ s ~ t nl ~ l4n ~
.3 ~ it ~ 1 ml ~ te- ~ pon ~ EiS ~ pH 7), ~ lt ~ C ~
; J ~ kti ~ ll * ~ 4u ¢ n ~ Ju ~ t ~ 4 pH ~ ~ nrlron iN ~, ~ olt b I ~
: ~ o ~ lt ~ ~ N; ~ O ~ 11ul ~ *, ~ 3u.st ~ e ~ pll ~), G '. C ~ s ~ ch4ntll1t) l ~ s (~ nt . j ;. ';'','' ~ '''';
~ "'''''~,,',~; li, ~.,:; ~;,;, ~ '~," ,, ", ~"""
Z1, ~, ~,? ~ `.54 lncub ~ e ù 2 ~ 'C p ~ nd ~ nt 2 h ~ ure ~ and a 1: ~ v ~ m ~ nt d ~
e ~ t ~ t'f ~ l-tu ~ for the back ~ ge of the actl ~ ~ blolo ~ l ~ u ~.
Fl ~ sour 1 pr ~ sel ~ te 1 ~ co ~ b ~ os ~ -r ~ pon ~ tu ~ FI, ~ s ~ rd ~ flbrobl ~ te.Y d ~ ~ ertn ~ hun7 ~ n .tA ¢ 1523) nde de 1 ~ f ~ r ~ I
Ab6cl ~ 3 ~ es: do ~ es ~ ef ~ ct ~ ur de cr l ~ s ~ n ~ e (p ~ / ml ~
~ r ~ onn ~ polJrcent4 ~ ed ~ 3tl ~ ulo lon 1 ~: bFCP ~ DS ~ pH 7 ~: bFGF ~ p ~ 7 V: bF 5F ~ ~ S ~ p ~ ~
A ~. ; b ~ OF ~ pH 9 o: bFGF I ~ 5 ~ p ~ l 2 : bFGr: ~ pl 1 2.
~ 5 L'~ ugment ~ t ~ on ~ 'incorpor ~ tlo d ~ thym ~ tlr ~ e tr ~ t ~ r ~ pre ~ ent ~ 1 ~ v ~ their number 9 eoupo p ~ r mlnute ~ cprn ~ obt ~ nude au plate ~ u de 1 ~ ceurbo d * ~ -r ~ pon ~ e ~ u ~ I: G ~ ' selll m ~ lns la v ~ r en epln ds thymld ~ trlt ~ lncorporee don6 le, 3 cell ~ en ~ b: ~ -an :: e ~ e FG ~ et ~ rmlné ~ d ~ n3 l ~
~) same ~ eXp ~ riqnee ~
Le T ~ ble ~ ulr ~ 3ume 1 ~ $ r ~ Ssull ~ t8 obt ~ nlJ ~ ~ ve ~
al: ~ t '~ t bt'GF, L' unlt ~ i de ~ tlmulation ~ t ai ~ bltralr ~ ment dorIn ~ ~ L for 1 ~ 4 ~ GI: or the bF ~ F ~ oc ~ dp ~ rt ln ~ ub ~ hang 2 ~ ur ~ 3 ~ Z ~. . . .
Tqk ~
_____ ~ _____._____ ~ ___ ____________ ~ _ ~
~ _____.___.___ ___ bl; '~ F ~ O'C). 9 ~ 1: 0 ~ (2 ~ 0- ~) S: ~ 13 3 ~ b ~ qF ~ DS ~ 2 Ii, 20 ~) 1 ~, 5 ~ FCr ~
o ~ 'OI;' ~) 'C) ~ G
cl'OI ~ + C ~ S ~ 2 I ~, 2 ~) 'C) ~, 5, ~ 2 ~ _ ~
: ~ 5 ',. , I, -i., ,. ,. ..: ~, ''. ',. :,, ~. : '.' , '! . : ''. .
'. ,:; ',,. '',, '''''I,'',,!':
', Z7) ~ ' {~ - Etf. ~ T! ~; T ~ n / ~ f ~ te !! ~ ~
p. , ~ ure ~ .t ~ i ~ ~ ~ h ~, C ~ ' Dat) 3 c ~ tt ~ p ~ rlenc6 ~, le ~ 0 pr ~ p ~ re Comm ~ ~ u poi.nt A ci ~ ~ e ~ slls, for the form ~ cid ~, at pÆr ~ recctmb ~; on ~ r ~ tlque pour la form ~ ba ~ iquçl d 'orl ~ In ~ hu ~ ln ~, ~ chet ~
~ upr ~ de 1 ~ 5 ~ clét ~ A ~ n, ~ rs ~ hsn ~ ~ u Cllnl ~ c ~ nc ~ ~ P, ~ rl ~), C'S4 Lncub ~ b 4'C, ~) C, 37'C or ~ O'C p ~ ~ d ~ nt d ~ erent ~ s p ~ rloul ~ s, in 1 'Qb ~ C ~ or in pr ~: ~ enc0 c ~ ~, 00, l ~ z; ~ ed ~ xtr. ~ ns u ~. f ~ t ~, p ~ d ~ D ~.
~ L ~
_ ~ _ ~ __________-_____, _______________ ~
4'C 0- 37'CGO'C
___________.____________________ _ .__. ~
. 'j bFCF t ~ 4 .~nn 1 I~F~iF t = 3~ r.nn 1 1 3, 5~ ;:)O
b~'Of: ~ DS t - 30 Ir.n 1 ! I
aFGF t Y ~ ml~ l ,~FCl': k ~ 30 n~n I I ~ ~ l os~
,'O ~F~F 1- [~S t = 30 rR~ O. 4 O, ~ O, 4 bFGF t - ~4 h~Ilre:3 l I
bl;OF t DS ; ~ ~4 h@ures I 1 ~CI: I 1 ~:;F ~ , 4 t:), 4 O, ~S bFGF t ~ 7 ~ours Z !3 ~ lOO
bFCF ~ D~ t = 7 J our ~ I 1 aFGF t ~ 7 ,~ ouI~ , 5 ~ ~ lOO
~r:~F ~ ~s t - 7 ~our~ 0, 4 O, 4 3 . _ __ ~______________ Lo~ donn~ r~pport~$ d~n~e ~ tobl~oux I ~t ~
lllu.ctr~t1t l'~ff~t protectBur tr~ procur~ p~r le ~ sùr le F~t:. Aln~;l, toutQ l~ octlYSt6 blolo Iqu~ du bFGF ~t corl~e~rv~ ctpr~$ 7 Jours d' ln~uba~tlon ~ 37'C, ~l~rs~ qu' ~.n 1' ~b;s~ncr: de t)S, aucune ~ct~ t~ n~ ~t~iL d~t~ctobl~.
3~ ', , :. . . : :
. ... . .
?
.. . ... .
~, . , E~ EI~PLI~ r~' APPL~ TION IN VIVO:
p~l- l men t o l. ;
Les op~ro~lons aont réoll~e~ ~ur dt~:s r~ts W~:,t~r m~le~3 de 300 t~ 400 ~r~mme.~. Ch~qu~ exp ri~nco t3~ f fect~e sllr ~Jne st~rl~ d~ 5 ~nim~u~.
~e p~s;
On prstlq~e deux typo~ dt~ pll- e~ cut~ et~ ~ur 1 It:~ ft~ce d~rs~le, p~ol~blem~nt r4s~e, t~ r~lmt~u~.
1) I.e:~; pr~l~vements ~t~nt ef~ectu~3 p~a emportQ-p~4ce o-~punch (0,6 crnl de di~m4tl~> 3usqu'~ plsncht r rnu~culalr~.
2~ DQ3 ~C srlflc4tion.~ d~ 1 c m de long 00nt prt~tlqu~e~ eu calpel. Elle.~ n' ~f fc~cte~t que~ 1~ rt~Slon dor ~o-Spl~t rmiqu~. .
.j . . .
L~ t~t?l~et:
S~lon 1~ typ~ d~ pl41~s, le3 le~ur~3 .s~nt tr~ltee~ p~r dlff~rent~ m~lan ~ dl3 pro ~lts en ~olutioll ~l~ns du :3lrum phy~iolo~ ue t~lnponn~ ~ 5 p~ 71 4~ ~t~rllls~.
Ce~ 301utioll~ 30nt d~p-~k~ p ur 1~9 pl~ a p~r punch d~n~ un t~mpon d~ eoll~sèn~ n~; ~tc~t~ pr-~d~bcoup~ ~u:~.
"j rn~urc~ e:c~etes de 1' ~xcl~ion ~l~3ul~1r .
D~n6 le ca~ de~ ~c~rlflcation , ~ 8 pl-oduit~ ~ont d~pos~l3 dlrrCte!mqnt ;i3CUei form@ llqulda ur la pl~
I..e~ effcto de ~ 9ocl~tlc;\n F ~ <b~lqua ou ~clcl~
au un m~l~n~ ~3n ~olutlon d~ I n~ ~ ~0 ~ml~ ~t ~
d-3xtrane4 ~ulf~t6~ n ~olutlon sl~ lO0 ~ ~ I m~/nil~ 30nt ~v~lu~ et eomparlSo ~ l' actlon te ch~cu I ds~s ~on~tltu~n~s, ct)nsld~r~3 ccmn~ témoirl3 d~ r~ction ~C llh~ Olutlon de d~o:301ul:~0~, FGF, dextr4ne r~ulfut-). L DS l~te~lt ~QlU
~i~ponlbl~ chc~ S~ÇMA ~0~5 1~ r~f~r~nc e~s~3.
.i?S
., '.'.
, .. ,.
., '', ', ' . , ' ' . ' ' ' ' ' .
~l Z ~ r5 ~
, "
~ h~que s~rl~ expérlment~le d' s lm~ux ~3t ~1~c~l f L~-3 b lnt~rv~lles d~ t~mp~ d4flnls p~r p~rlo ~ de ~4 i-eurQs, ~t 1~ re~ions 1~6Se3 ~ont p~elev~e~ pour cl I~X t~p~3 d' ~tudes:
1~ un~ ~n~ly~e morphologlq~le ext~-n~ ~ ~e pl4r~ ri~ de 1~ pl~
2) ~no 6tude hlcto~oglque.
Résult~t~;
. ~1~ ~, vlyo Ç~. ~ ~ ~
bu F~F m~rqu~ rnt~o~ctlven~en~ l' ls~de I 125 ~st dépo.s~ en p~ nce ou ~n ~' 4b~ence d~ Il;tr~na~ aulf~t~a cl~ns ~n t~mpen d~ coll~ ne ~selon l~ p ~otoeol~ d~crl t par l~o~nner 1~1. et coll, d~ns ~Proc. Natl. J~C ~d. Sc (US~
pOZ~-5 'jo~-502s ~ ~9B~> )~.
L4 v~ri~tlon de l~ rodlooctlvl :1~ d~n~a le coll~g~n~
`~ irnprlSy;n~ e~t ~ppr~cl~e ~n fonct~on tu te 3np~ <f~su~rs 2).
717~L~ d~ 1~ f~, J~e Abc ls~ t emp:3 en h~3ur~
~rdonn~eY ~ 18 ra~oe~ct 1 ~t~ m~ uré~ p~
rapport ~ l~ r~dio~ctlvlt~ el' C ~lgln~
bFOF ~ DS
.,~5 coll~g~na x--- x bFO~
bF~3F
2 cm ~o l~l plol~ {
bFOI~ ~ ~S
Ln r ~dlt~ctlvlt~ ~st me~ur~ ~n~ 1 cla collt~ n~ e~ d~n6 de~ pr~l~v~DleAtl3 ~ff~ t~t41~ ~n p~ph~rle do l~ pl~c, h ~ crn de ~cllc-el, p~r un pun~h Ibquivol~nt celu~ d' c~rl~slne.
;~
2l~0~ 4 I I - E ~ ~ orp.~Qls~ SI ues ~ ~1 ~3n~ L5U~.
A) ~oie~. phr emp.~r~ pi~,; .
~) Etude morphologique t L~ ob~ervl~tlor d~ volut~on ~ ~ pl~o~ ~ 1' oeil nu perm~t de c~n~t~t~r une actlor t~ r att~ ~
1'~s~o~l~tion FG~ ~ cloxtr~n~ ~ulfQt~ ~u 14 vlt~ et la qu~l~t~ de 1~ c~c~trls~tlon super~lc~el~ ~pldcro~ tl~n lys~ du ~lllot ).
1~3 , 1 ) Apras 24 heur~s, le~ tAmpono de co3 l~n~ ~rnpr~n~
p~r e~tte ~socl~tlon ont tot~lamær ~ ~dhkr~ aux p~rols d~ 1~ pl~ie, et ne peuvent ~tr~ pr 1QV~ que p~r 1~310n des tls~u~ r~ r~s. Le3 exp~r~e ~t~tlon3 t~oin~ n~
m~nlfe~t~rlt uno ~h~r2nc~ tot~le d ~ co~ n~ qu' ~u bout d~ 3~ ~ 48 h~ur~.
2) Le~ r~plthéllo~tlon ~:~t vl~l'ole ~ ' o~ll nu ~u bout a 3~ml3 jour en pré ence de l'~ssocl~ lon FC~ ~ de:;tr~ne :iulfate, ~lo~-~ q~' ur~e Im~a~e i~enti ~le Igu~ le~ m,~ln~
d~mand~ de:3 t~mp~ d' exp~^lment~tlo ~ 7 ~.~ur~.
3) /~n~ly~ pl~nl~n~trlg~ In4~lySl~t l~nim~trlqu~ ao 1~
~urf~cc extel-n~ de~ pl~ moil~rQ ' Qbsenc~ t~,gole de r~tr~ction ~o~ t~su:~ ~n r~ n~r~l: on.
2~ L~ t~bl~aux 3 et 4 r~pp~r~on l~o moyen~e~ de cinq e~pérlencasl ln~éporldant~ conc~rn~ t:
~: L.e r~appor~ ~xprlbnb ~n pou c~rlt~ge~, d~ la 3urfacc de 1~ clc~trlco t~l ~ln ~ de L~- surf~ce de la cic~trlec tru~t~ p~a dlff~rent~
3v o~$~ci~t lons.
.Q~,: Le roppol-t du ptlrLmbtr~t ~ ~h~gu~ cic4trlc~
~ec la ~urf ace de c~3 m~m~ ~ ci~trlca~.
., ~!j '~.
.' 2i~ .54 1~
L' ~s~ocl~tlon FCF ~ dextr~n~ 8 lf~te d~n.~ le 3~pport coll~ ne ~T~ble~u 3) permee un0 clc~trl~tlon plus h~rmo~leuse, pr~,3entnnt une fo~ble r~tr~ tl.on ~es t~6suo ~102, 58'~, ~u Jour B, c~ntre 49, 27 % ~V~I: 0~ ~-Yl).
~ï De plu~ ' a~p~act clrc~lolr~ ~ la pl~le ~e eons~rv~ d' ~ut~nt ml~ux ,~u COUI~ de l~ c ~trl~otl4n que le r~pport p~rlr~tre P t~ 1~ pl~le ~ ~urf4c ~ d~ plDle exprl~ dQn~ læ T4b~e~u 4 ~ot plu~ f~Lbl . LA Y~ r dl3 C~
r~pport perm~t de cQr4ct~r~ser lel confor ~tlon ~e 1/~ pl~le 1~ en cour3 ~a cic~trl3l~t lon. L~:3 vQl6~uro o~ plU~ f~ ble~s sont enre~l st r~:3 p~r 1 ' 4~socL~t lon F~P d~xt r~ ul ~t e dan~ l¢q E;81~ de ooll~z~ne. ~in31, ~1~ J ur 8, le rCIpport P/S ~t d~ 0, 22, ~lor~ que, pou~ le FG~ ~ul, la v~eu~ e.~t de 0, 3!i~, ~en~l~lem~nt l~enti~ue ~ c~llo bt~r~u~ dor~- 193 l~ témolns sans colla~s~n~. Les ple~ t~m~ ,h~ clc~trl~en~ p~r r~pprochement de~ re~ et prennoAt w ~p~ct ov~ î orme.
Ce~l est ~3;ule~ent lllu~l:r~ d~n~ 1~3 phC :o~r~phle~ de~ f~ce4 dora~l~3 ~ nln)~u~ t r~lt~
~O~q~ B le t~
5urf~c~ d~ la pl41e t~n~oin (- ~3olutlon F lyololoP:lqlle) ~ ___ ___ .__ _ ____ Produit~ ~oll~;~nq Col~ ~3~n~! Collu~ne Col laé;~sne + I~S ~ ~ F~F ~ b~F ~ ~S
~ul 50~ g~ml I ~ sOm~ t Jours 500 ~6~ml ~ - -2 80, 7~ 1;1, 43 7 , C~ 0 3 ~0, 43 9'~, 54 1~ , 127 174, 42 g~, 79 77, 08 ~5 , I I 1 l 7, 24 3V 8 92, 409~, 14 ~ , a7:lO~, 51g ___ ________~________ _ _ .__~__ _ ~ ~ _ _ _____ _ __ 3g '..' -~: ~
,~, T~ ~.
R~ppGrt F~/~ du p~ tr~ ~e 1~ pl~le :~u 14 ~urf~c~ ~ c~,t~
pl a l ~ .
~rodult~ Gc~ g~n~ Coll~no c~ bn~
T~oln Col~ e~ b~O~ ~ ~S ~ FOF
~ns I t~i 000 ~5 5C10 ,~lg ~t ~v~r~; coll~nQ~ I ~g . -, ~ ~__ ____ _ _ _ _ O, 1~ O, Z2V,~5 C~,20 0, 19 2 ~ 0, ~10, ~5 0~ Z~ C~, t~
.~ 0, 22 0, 360, 16 0, ~'6 0, 1 4 0, 3~ 0, 20t~, t7 ~ Cl, t~
6 0, :~7 ~ 8 0, ~5 C~, 15 ~,7~ ~,4~0,39 C~,4 I .5 b L~s r~lonc~ tr-~lt~e:3 ~30nt pr l~v~o, flY~r~
lMr~rt!3n,$~ n p~f f l rl~. L' ~t ud~ hio olo~ st r~
'- ~u;~ Ollpii~ia d-~ 7 Jlm. Les; color~tlo s utL11~3 p~rM~tt~nt d~ tud~3.s topo~r~ph1qu~ hl~tochL~lque~.
l.e~ fig~ s ~, 4 7 sont d~ p oto~r~phle~ ~ro~.
d~ up~ h.~tolo~qu~3, obtenu~ ~ 4 o~r~i pour 1~
î i,~5ur~ 3, 4 5 ,Jour~ pour 1~ flsur~ 4 ~ ~ 3 Jour~ pour le,, '5 f i~,u~5 ~ 7-Flg. 3 ~ 0) r~prb~nt~ r oult~t~ ~bt~nu4 ~ rc u c411~ n~ ul ~ t ~ol n ~ ~ t ~Pl~. 4 t.; 25~) r~pr~ r~t~ le~ r ~U1~4t~ $1m~1~1res avec 1' ~ ocl~t ~or~ ~)S t PGP ~an 1~ ~o~ n~ t ~- ~F~S. 5 SX S003 repr~ nt~ un d~l 411 d~o ~ u;a ~n r~n,~r~t lon col-r~l~pord~nt 3 14 ~l~ur~t 4.
Fl~$~ 6 et 7 ~7~ 2gO) reprbsentan cl-~ r~.~ul~4t~
~:lc,~t~ tlon.~ d~ pl~le:~ obt~n~J re,~p~:tlv~m~nt ovec un~ ~Otl.Jt lon phy;ilûlozlqu~ t~o n ~t ~v~ un oc l ~ t l c,n ~FCiF~ t r~n~ sul f ~ ~.
',.'' .. . . . . . . . . ............................ ..
: . . . ` ~ .
~CV aY'X~rox T~l~copl~r 702U ,10- 4-89; 11:49 ;33 1 874 51 37 ~ , ~, S & H;~ 1 . . .
" ' 2q~.. 3¢'~i5 CO
V~n3 1~, ~xp~rler~cec ropport~ ~ n r~f~r~anc~ au;;
s 3 ~ S, on a utllls~ ~es m~e~ o~pos~tlons qu~
c~lle~ lndl~u~ u t~ble~u 4.
L~ an~ly,~ h~stolc,gique d4D~on~ r~ q~e 1' ~sl~ocLatlon ~ + VS accélbre les ét~p~!a tr~dlt10n~ lleQ de 1 elcatrlsotion d,~rrn~-~plderD~ ue et eua: Dnte 1~ qu~ de.
t~:3us reconstl~u~-~ p~r rapport ~x o~ ~ nt~tlons t,~ oin.s (~oll~3~ne sf~ul~. A~nsl, en pl S~-lnc6 du F~F +
~e:~trane, un~ colonl~t lon tr~s rapld~ ~I Jour~ de~a c~t~gorleO c~ lalre~ ~n~lronnante$ ~ 1l~obl4s~eo, sru~cul~LrC3 lls~ ;) e:,~ o~s~rv~e ~ por Sr d~s t ~ssUs ~ ln3 ;.~Lns, et, ~n partlcull~r, ~ p~rt~r du con,~onet1~ ~u pl anc h e r mus,: u l o 1 r e~ s t r ~ 3~ c ~nt .
~ an~ m~ k~mps ~f l~ure 5 , une n~o4n~iea~en~sQ
1~ perMet ~u tLss~- en f~r.~atlen d' ~tre co on~ p~r une d~.nslt~
t~ for.,~ de capill~ire;; ~an~sulns ~d~ l~n~ p~r le ~hlffre ct~ r~fbrence 10 ~ur cett~ fl~re), d~ll 1~; t~s.su:~ en r.~ n~r~Slon dk~ign~s par le ehlffr~l d r~fkrenc~ 11. /~u L~ou~ dc ~ ~our:~ ~contr~ 5 h ~ pour le~ t~oin~
.0 r~plth~l ~6~t ~on cngagke ~ partlr t~ 1 ~pldeeme d~ re~
J~ 1~ pl~lc arrive ~ affronte~ent. L' p~der~n~ est S,;,~t,31em~nt réor~an~s~ ~3t il pr~entQ u ~ d~nslt~ norm~l~
~f.3u~-e ~, 4~1ne J~r~ cor~.p~otlveo~ent ~,IX tg3toln~t 4 1 d~n~lt~ c~llul~ b,~uco~p plu~ f~l ~ re 3 ~,5 5~.ne ~our~. Ce~ meme3 l~lu~tr~tlor~ts r ~ nt 1' ~b~nce d~
r~tr~t~on d~s bor~s dQ 1~ plzL~ powr ~t8 punchs ~t-~lt~:7 p~r l'assocl4tlon F~F ~ D5, contr~lrem~ne ux t~olns qul C~th~ 3nt pat- r~tr~ctlon le.~ tls~u3 exc 8~.
La clc~tr~sation d~ plala~ b~onue~ p~r scarlflcatlon ~t ~valu~e p~r u~e ~tud hlotclo~lqu~
.3ffe~tu~ 5 Jour3 ~pr~s ~'op0ratlon. ct traltQmer,tt con~l3te 2n un~ ~eule ~ppllc~t ion top~ue ~tJ nl ~o~t d~ 1~ le~lon l~a - m~m~ de l'opkt~~tlon. L~s r~sult~ .o ~ont pr~ent~r~ ~u~
1~5 tl3ur~.~ 6 et 7 c~u$ mont~nt le:a tl ~iiu~ de 1~ p~ y~nt ;~5 recu un~ s-~lutlon phyJ.lolo~lqu~ t~mo~ ~ r~ t 1~ aJo~ t Ivn d~ b~GF re,:om~1n~nt ~ de~ ;r~n~ ~ulf~e <~ n,~
, .
R~V ~r:x~rox -lel~copler ~lu~u ilU~ 51 ;33 1 ~74 51 37 ~ q, S & H:#
Xl .r:ri~ ~t 5~ e cle:~tr~n~ ,ulf~te pD ~ ) pour 1 r L ~r u ~ ~l '.' .
' 1 e ~ t ~ n-~t er .~ ue l a présenc de 1 ' a~scc S ~ t l Gn lndui~ 1 ' er.clench~ment de:a mkcarilsme3 c cntrlciel~ qui ~etnblent totnlem~nt t~rminé3 au 3~n~e Jo r ~uiv~nt 14 bl~:3sur~ ure ~). L.' ~plder~e p4r~P:i ~aent recoR~t ltu~
~,urn~ont e un ~erme ~ns~, prS~nt~n~ W~l~ orgMnl~t lon 1r~dl:,cerna~1e des tlssu3 envlronnDnt . ~n r~v~nch~
cl-~atri~tlor~ ~u té~l~oln Cflgur~ 6~ t ~r3 las o~s t~ 6 'a de t~mp~ n~chevee. L' ~pld~r~ plu3 1~ ~ ot p~r~tlell~-ment r~con~tltu~ t le denP~ s~u~;-Joc~ t pr~ente un~
.,lt~ ~r~3 ldche et un~ ~r~nl ~t~or no~hlclu~ c de., c e11~ n~c l~os~s.
L' ~ocidtton ~SF + dextrun~ ulf~t~ pr~nt~
: t ca~.r,rn~r un pui.;~ t a~,r~nt c~ trls~nt In I ~ cc;~l~r~n- .~' une ~,3r; ~ r,~r~sus nutllr~l~ rt~ r~tlf , ~t per.~-3~t4nt ~' outr~ p~rt une qur31Lt~ accru~ d~ 1~ C cotrl~otlon p~r ,s~n- a ;3-~ tout F,h~n~m~n~ de r~trac~l I~ b unq It~obili:~atlon r~pld~ -J~, dlffér~nte3 c~t ~orl~s c~liull~lr~:, n~-c;~ .;,1r~ ~ la r~st~ur~t'on ti~sul~lr ~.
P.~ur mie~ 1 l l ust r~r 1 ' obJ~2t o prb~ent o irr~nt, ~ n, ,~n ~ en ~cl~lr~ m~l~t~n4nt u,21q~ n)pl~ e : .
l:r~ tL;~.rl~ Ji r:e siont en ~uc~no f4~; i~ de$tlnS3 ~ ~n llrnltsr 1~ p~r;~.
;~.'i G, '.~"r~ i p l~ r ~ p~ r a ~on p '~ c r em~
~n pr~por~ la composit~on su v-nte:
F~F ., ., ................ , ..... .. ,, .. ,, .. , 10 )I~, ~O !::ax~r4ne ~ul~t~ ~n' P5660 .~u c~4 42~u~ 51~ns) . ~O m~
C~rl~oxy~,~th)~l c~ lo~ .. ............. '`. 5 ~,~
ED U PUr 1fi~ :st~r11* ~t ~pyr~ n~a ...... 1~ ml ~n ot~tlent .~insl un~ ~r~ma q e 1' on ~ppllqu~ rT~rl~lt) ,. ct ~iolr ~,ur ur~3 pl~l~ dq Syp~: sci~r~Lc tLon, our un r4t. ~n t ;~ ur.e~ trl~ ,3tlc.~n ~pr~3 3 ~OUI~ c~ traltornl~nt.
`: . , ', , ' ~ ,,.' ,;,. , ', ' ,. .,. ,, ' :~, .
RCV B':Xerox T~l~copi~r 7~20 ;10- 4-as, 11:52 .33 1 ~74 51 37 ~ C., S ~ H:# 3 r 2;1;
6.~
r,,~!~r~ r. ?. P~ ~.p.~ ,r~ Jr~ n~m.~
~ ~ s~pp~rt ue~ c,t un fll ~ coll~ne ~:~.~ti.: te rlU~ S (i~ S.~cl~t~ "F~ t~C~ L~n) t;~ rllm ~t, i:n~rC3rl~ par ~dsorptlerl pa~s~v~3 du m~ll ~se FGF-d~xtr;~ne !i 3ulf~t~w dPwn~ prepol tlons s~lv~n~
Fr,F .... ~ ,,,,, ....................... , .. 10 ,u, ~e,;tran~ ~ulfat~ ~n- ~5~50 ~u catal 3aSu~ 51zm~ O
~al~2. 1~ J.~l de s~ru~ physlologlqu~ ~t~ lo ~t ~pyr~g~
r~ fblt lr~cuber p~n~nt 3~ ~lnute.a ~ 4~C. I.e p~n~ nt obtenu, d~,eupabl~ ~ ' a forn~e ~ l a pl~ t nsu1,t~a sc~ eu~
v~ d.~ empaqu~e.
Il p~t ~Sr~ elppl1q~ a.~ ce:~ ' yl~r4~ion~
L,rOlur~3s, d* c~upure.~ et de plal~, prol ~nd~.
F.~ t,~l ,r. ~~ r~ n f ll ~ ~
L~ rr.~ e pr~par~t lon qu~ cl-~ s$u~, 41n~: oua le tnr5;n~ me:!~ op~ratoire, p~u~nt servir ~ impr~gner un utur~ c~lrur31ce~1 ~t~;F~ ~ehlcon - V1cl yl E~VZ). L~ fll .
~7 iutrul-L ot~tenu e:jt utilis~bl~ ~n chtru~ ~o.
15l~l.E ,4: Fl ~ r~tl~n, ,~' un .411~r~
On pr~p~r~e 13 compos' ~ I~n su vunte;
Y~.~` .. , .,,,,, .,,,,,,,,,,,, .............. ~ 0 r.3 D~:~tran~ 6ulfi~t~ ~n' D5650 cu C~ltA c13ue S~.sm~) . 150 L~rrn~3 ~rtlfici~ oe .......... ............. 3 ml 011 ~ff~ctu~ In rn~l~nge p~ r~ lyophlll~tiorl, pu~ n 4Jol~tr: 3 ml d' e~u purl~i~e :~t~ llo apyr~ ou cnt d~ I'em7p1ci.
Le coll.~ri3 a.;.t 4ppliqu~ ~nx lcts c~$ d' ul~ær,~L ion ~-7 1~l .orn~e, 4 rals,~n de ~euY. ln~tlll tl~n$ p~r ~our.
'~5 4'C 0- 37'CGO'C
___________.____________________ _ .__. ~
. 'j bFCF t ~ 4. ~ nn 1 I ~ F ~ iF t = 3 ~ r.nn 1 1 3, 5 ~; :) O
b ~ 'Of: ~ DS t - 30 Ir.n 1! I
aFGF t Y ~ ml ~ l , ~ FCl ': k ~ 30 n ~ n II ~ ~ l os ~
, 'O ~ F ~ F 1- [~ S t = 30 rR ~ O. 4 O, ~ O, 4 bFGF t - ~ 4 h ~ Ilre: 3 l I
bl; OF t DS; ~ ~ 4 hrs @ ures I 1 ~ CI: I 1 ~:; F ~, 4 t :), 4 O, ~ S bFGF t ~ 7 ~ bear Z! 3 ~ lOO
bFCF ~ D ~ t = 7 D our ~ I 1 aFGF t ~ 7, ~ YES ~, 5 ~ ~ lOO
~ r: ~ F ~ ~ st - 7 ~ our ~ 0, 4 O, 4 3 . _ __ ~ ______________ Lo ~ donn ~ r ~ pport ~ $ d ~ n ~ e ~ tobl ~ oux I ~ t ~
lllu.ctr ~ t1t l ~ ff ~ t protectBur tr ~ procur ~ p ~ r le ~ sùr the F ~ t :. Aln ~; l, toutQ l ~ octlYSt6 blolo Iqu ~ du bFGF ~ t corl ~ e ~ rv ~ ctpr ~ $ 7 Days of ln ~ uba ~ tlon ~ 37'C, ~ l ~ rs ~ que ~ .n 1 '~ b; s ~ ncr: de t) S, none ~ ct ~ t ~ n ~ ~ t ~ iL d ~ t ~ ctobl ~.
3 ~ ', , :. . . ::
. ... .
?
... ...
~,. , E ~ EI ~ PLI ~ r ~ 'APPL ~ TION IN VIVO:
p ~ l- l men to l. ;
The op ~ ro ~ lons reoll ~ e ~ ~ ur dt ~: sr ~ ts W ~:, t ~ r m ~ le ~ 3 de 300 t ~ 400 ~ r ~ mme. ~. Ch ~ qu ~ exp ri ~ nco t3 ~ f fect ~ e sllr ~ Jne st ~ rl ~ d ~ 5 ~ nim ~ u ~.
~ ep ~ s;
We prstlq ~ e two typo ~ dt ~ pll- e ~ cut ~ and ~ ~ ur 1 It: ~ ft ~ ce d ~ rs ~ le, p ~ ol ~ blem ~ nt r4s ~ e, t ~ r ~ lmt ~ u ~.
1) Ie: ~; pr ~ l ~ enements ~ t ~ nt ef ~ ectu ~ 3 p ~ a emportQ-p ~ 4ce o-~ punch (0.6 crnl di ~ m4tl ~> 3usqu ~ plsncht r rnu ~ culalr ~.
2 ~ DQ3 ~ C srlflc4tion. ~ D ~ 1 cm long 00nt prt ~ tlqu ~ e ~ eu calpel. It. ~ N '~ f fc ~ cte ~ t que ~ 1 ~ rt ~ Slon dor ~ o-Spl ~ t rmiqu ~. .
.j. . .
Summer ~ and:
S ~ lon 1 ~ typ ~ d ~ pl41 ~ s, le3 le ~ ur ~ 3 .s ~ nt tr ~ ltee ~ p ~ r dlff ~ rent ~ m ~ lan ~ dl3 pro ~ lts en ~ olutioll ~ l ~ ns du: 3lrum phy ~ iolo ~ ue t ~ lnponn ~ ~ 5 p ~ 71 4 ~ ~ t ~ rllls ~.
Ce ~ 301utioll ~ 30nt d ~ p- ~ k ~ for 1 ~ 9 pl ~ ap ~ r punch d ~ n ~ a t ~ mpon d ~ eoll ~ sèn ~ n ~; ~ tc ~ t ~ pr- ~ d ~ bcoup ~ ~ u: ~.
"j rn ~ urc ~ e: c ~ etes de 1 'xcl ~ ion ~ l ~ 3ul ~ 1r.
D ~ n6 the ca ~ of ~ ~ c ~ rlflcation, ~ 8 pl-oduit ~ ~ have d ~ pos ~ l3 dlrrCte! mqnt; i3CUei form @ llqulda ur la pl ~
I..e ~ effcto de ~ 9ocl ~ tlc; \ n F ~ <b ~ lqua ou ~ clcl ~
au un m ~ l ~ n ~ ~ 3n ~ olutlon d ~ I n ~ ~ ~ 0 ~ ml ~ ~ t ~
d-3xtrane4 ~ ulf ~ t6 ~ n ~ olutlon sl ~ lO0 ~ ~ I m ~ / nil ~ 30nt ~ v ~ lu ~ and eomparlSo ~ actlon te ch ~ cu I ds ~ s ~ on ~ tltu ~ n ~ s, ct) nsld ~ r ~ 3 ccmn ~ Témoirl3 d ~ r ~ ction ~ C llh ~ Olutlon de d ~ o: 301ul: ~ 0 ~, FGF, dextr4ne r ~ ulfut-). L DS l ~ te ~ lt ~ QlU
~ i ~ ponlbl ~ chc ~ S ~ ÇMA ~ 0 ~ 5 1 ~ r ~ f ~ r ~ nc e ~ s ~ 3.
.i? s ., '.'.
, ..,.
., '', ','. , ''. '''''.
~ l Z ~ r5 ~
, "
~ h ~ que s ~ rl ~ experiment ~ le d 's lm ~ ux ~ 3t ~ 1 ~ c ~ lf L ~ -3 b lnt ~ rv ~ lles d ~ t ~ mp ~ d4flnls p ~ rp ~ rlo ~ de ~ 4 i-eurQs, ~ t 1 ~ re ~ ions 1 ~ 6Se3 ~ have p ~ high ~ e ~ for cl I ~ X t ~ p ~ 3 of ~ studies:
1 ~ a ~ ~ n ~ ly ~ e morphologlq ~ le ext ~ -n ~ ~ ~ e pl4r ~ ri ~ de 1 ~ pl ~
2) ~ no 6 study hlcto ~ oglque.
Result ~ t ~;
. ~ 1 ~ ~, vlyo Ç ~. ~ ~ ~
bu F ~ F m ~ rqu ~ rnt ~ o ~ ctlven ~ en ~ l 'ls ~ de I 125 ~ st Dépo.s ~ en p ~ nce ou ~ n ~ '4b ~ ence d ~ Il; tr ~ na ~ aulf ~ t ~ a cl ~ ns ~ nt ~ mpen d ~ coll ~ ne ~ according to l ~ p ~ otoeol ~ d ~ crl t by l ~ o ~ nner 1 ~ 1. et al, d ~ ns ~ Proc. Natl. J ~ C ~ d. Sc (US ~
pOZ ~ -5 'jo ~ -502s ~ ~ 9B ~>) ~.
L4 v ~ ri ~ tlon de l ~ rodlooctlvl: 1 ~ d ~ n ~ a le coll ~ g ~ n ~
`~ irnprlSy; n ~ e ~ t ~ ppr ~ cl ~ e ~ n funct ~ on tu te 3np ~ <f ~ su ~ rs 2).
717 ~ L ~ d ~ 1 ~ f ~, J ~ e Abc ls ~ t emp: 3 in h ~ 3ur ~
~ rdonn ~ eY ~ 18 ra ~ oe ~ ct 1 ~ t ~ m ~ uré ~ p ~
report ~ l ~ r ~ dio ~ ctlvlt ~ el 'C ~ lgln ~
bFOF ~ DS
., ~ 5 coll ~ g ~ na x --- x bFO ~
bF ~ 3F
2 cm ~ ol ~ l plol ~ {
bFOI ~ ~ ~ S
Ln r ~ dlt ~ ctlvlt ~ ~ st me ~ ur ~ ~ n ~ 1 cla collt ~ n ~ e ~ d ~ n6 de ~ pr ~ l ~ v ~ DleAtl3 ~ ff ~ t ~ t41 ~ ~ np ~ ph ~ rle do l ~ pl ~ c, h ~ crn de ~ cllc-el, p ~ r un pun ~ h Ibquivol ~ nt celu ~ d 'c ~ rl ~ slne.
; ~
2l ~ 0 ~ 4 II - E ~ ~ orp. ~ Qls ~ IF ues ~ ~ 1 ~ 3n ~ L5U ~.
A) ~ goose ~. phr emp. ~ r ~ pi ~ ,; .
~) Morphological study t L ~ ob ~ ervl ~ tlor d ~ volut ~ on ~ ~ pl ~ o ~ ~ 1 'eye nu perm ~ t de c ~ n ~ t ~ t ~ r an actlor t ~ r att ~ ~
1 '~ s ~ o ~ l ~ tion FG ~ ~ cloxtr ~ n ~ ~ ulfQt ~ ~ u 14 vlt ~ and the qu ~ l ~ t ~ de 1 ~ c ~ c ~ trls ~ tlon super ~ lc ~ el ~ ~ pldcro ~ tl ~ n lys ~ du ~ lllot).
1 ~ 3, 1) After 24 hours, the ~ tAmpono of co3 l ~ n ~ ~ rnpr ~ n ~
p ~ re ~ tte ~ socl ~ tlon ont tot ~ lamær ~ ~ dhkr ~ aux p ~ rols d ~ 1 ~ pl ~ ie, and can ~ tr ~ pr 1QV ~ only p ~ r 1 ~ 310n tls ~ u ~ r ~ r ~ s. Le3 exp ~ r ~ e ~ t ~ tlon3 t ~ oin ~ n ~
m ~ nlfe ~ t ~ rlt uno ~ h ~ r2nc ~ tot ~ le d ~ co ~ n ~ que ~ u after ~ 3 ~ ~ 48 hours ~ ur ~.
2) The ~ r ~ plthéllo ~ tlon ~: ~ t vl ~ l'ole ~ 'o ~ ll nu ~ u bout a 3 ~ ml3 day before the ~ ssocl ~ lon FC ~ ~ of:; tr ~ ne : iulfate, ~ lo ~ - ~ q ~ 'ur ~ e Im ~ a ~ ei ~ enti ~ le Igu ~ le ~ m, ~ ln ~
request for: 3 t ~ mp ~ of experience ~ tlo ~ 7 ~. ~ ur ~.
3) / ~ n ~ ly ~ pl ~ nl ~ n ~ trlg ~ In4 ~ lySl ~ tl ~ nim ~ trlqu ~ ao 1 ~
~ urf ~ cc extel-n ~ de ~ pl ~ moil ~ rQ 'Qbsenc ~ t ~, gole de r ~ tr ~ ction ~ o ~ t ~ su: ~ ~ nr ~ n ~ r ~ l: on.
2 ~ L ~ t ~ bl ~ aux 3 et 4 r ~ pp ~ r ~ on l ~ o moyen ~ e ~ de five e ~ perlencasl ln ~ thrilling ~ conc ~ rn ~ t:
~: Le r ~ appor ~ ~ xprlbnb ~ n pou c ~ rlt ~ ge ~, d ~ la 3urfacc de 1 ~ clc ~ trlco t ~ l ~ ln ~ de L ~ - surf ~ ce de la cic ~ trlec tru ~ t ~ p ~ a dlff ~ rent ~
3v o ~ $ ~ ci ~ t lons.
.Q ~ ,: Le roppol-t du ptlrLmbtr ~ t ~ ~ h ~ gu ~ cic4trlc ~
~ ec la ~ urf ace de c ~ 3 m ~ m ~ ~ ci ~ trlca ~.
., ~! j '~.
. ' 2i ~ .54 1 ~
L ~ s ~ ocl ~ tlon FCF ~ dextr ~ n ~ 8 lf ~ te d ~ n. ~ Le 3 ~ pport coll ~ ne ~ T ~ ble ~ u 3) permee0 clc ~ trl ~ tlon plus h ~ rmo ~ leuse, pr ~, 3entnnt a fo ~ ble r ~ tr ~ tl.on ~ es t ~ 6suo ~ 102, 58 '~, ~ u Day B, center ~ 49, 27% ~ V ~ I: 0 ~ ~ -Yl).
~ ï De plu ~ 'a ~ p ~ act clrc ~ lolr ~ ~ la pl ~ le ~ e eons ~ rv ~ d '~ ut ~ nt ml ~ ux, ~ u COUI ~ de l ~ c ~ trl ~ otl4n que le r ~ pport p ~ rlr ~ tre P t ~ 1 ~ pl ~ le ~ ~ urf4c ~ d ~ plDle exprl ~ dQn ~ læ T4b ~ e ~ u 4 ~ ot plu ~ f ~ Lbl. LA Y ~ r dl3 C ~
r ~ pport perm ~ t cQr4ct ~ r ~ ser lel confor ~ tlon ~ e 1 / ~ pl ~ le 1 ~ in cour3 ~ a cic ~ trl3l ~ t lon. L ~: 3 vQl6 ~ piss o ~ more ~ f ~ ble ~ s are enre ~ l st r ~: 3 p ~ r 1 '4 ~ socL ~ t lon F ~ P d ~ xt r ~ ul ~ te dan ~ l ¢ q E; 81 ~ de ooll ~ z ~ ne. ~ in31, ~ 1 ~ Jur 8, the rCIpport P / S ~ td ~ 0, 22, ~ lor ~ que, pou ~ le FG ~ ~ ul, la v ~ eu ~ e. ~ T
0, 3! i ~, ~ en ~ l ~ lem ~ nt l ~ enti ~ ue ~ c ~ llo bt ~ r ~ u ~ dor ~ - 193 l ~ Témolns sans colla ~ s ~ n ~. The ple ~ t ~ m ~, h ~ clc ~ trl ~ en ~ p ~ r r ~ pprochement de ~ re ~ and prennoAt w ~ p ~ ct ov ~ î elm.
Ce ~ l est ~ 3; ule ~ ent lllu ~ l: r ~ d ~ n ~ 1 ~ 3 phC: o ~ r ~ phle ~ de ~ f ~ ce4 dora ~ l ~ 3 ~ nln) ~ u ~ tr ~ lt ~
~ O ~ q ~ B le t ~
5urf ~ c ~ d ~ pl41e t ~ n ~ oin (- ~ 3olutlon F lyololoP: lqlle) ~ ___ ___ .__ _ ____ Product ~ ~ oll ~; ~ nq Col ~ ~ 3 ~ n ~! Collu ~ ne Col laé; ~ sne + I ~ S ~ ~ F ~ F ~ b ~ F ~ ~ S
~ ul 50 ~ g ~ ml I ~ sOm ~ t Days 500 ~ 6 ~ ml ~ - -2 80, 7 ~ 1; 1, 43 7, C ~ 0 3 ~ 0, 43 9 '~, 54 1 ~, 127 174, 42 g ~, 79 77, 08 ~ 5, II 1 l 7, 24 3V 8 92, 409 ~, 14 ~, a7: lO ~, 51g ___ ________ ~ ________ _ _ .__ ~ __ _ ~ ~ _ _ _____ _ __ 3g '..' - ~: ~
, ~, T ~ ~.
R ~ ppGrt F ~ / ~ du p ~ tr ~ ~ e 1 ~ pl ~ le: ~ u 14 ~ urf ~ c ~ ~ c ~, t ~
pl al ~.
~ rodult ~ Gc ~ g ~ n ~ Coll ~ no c ~ bn ~
T ~ oln Col ~ e ~ b ~ O ~ ~ ~ S ~ FOF
~ ns I t ~ i 000 ~ 5 5C10, ~ lg ~ t ~ v ~ r ~; coll ~ nQ ~ I ~ g. -, ~ ~ __ ____ _ _ _ _ O, 1 ~ O, Z2V, ~ 5 C ~, 20 0, 19 2 ~ 0, ~ 10, ~ 5 0 ~ Z ~ C ~, t ~
. ~ 0, 22 0, 360, 16 0, ~ '6 0, 1 4 0, 3 ~ 0, 20t ~, t7 ~ Cl, t ~
6 0,: ~ 7 ~ 8 0, ~ 5 C ~, 15 ~, 7 ~ ~, 4 ~ 0.39 C ~, 4 I .5 b L ~ sr ~ lonc ~ tr- ~ lt ~ e: 3 ~ 30nt pr l ~ v ~ o, flY ~ r ~
lMr ~ rt! 3n, $ ~ np ~ ffl rl ~. L ~ t ud ~ hio olo ~ st r ~
'- ~ u; ~ Ollpii ~ ia d- ~ 7 Jlm. The; color ~ tlo s utL11 ~ 3 p ~ rM ~ tt ~ nt d ~ tud ~ 3.s topo ~ r ~ ph1qu ~ hl ~ tochL ~ lque ~.
the ~ fig ~ s ~, 4 7 are d ~ p oto ~ r ~ phle ~ ~ ro ~.
d ~ up ~ h. ~ tolo ~ qu ~ 3, obtained ~ ~ 4 o ~ r ~ i for 1 ~
î i, ~ 5ur ~ 3, 4 5, Jour ~ pour 1 ~ flsur ~ 4 ~ ~ 3 Jour ~ pour le ,, '5 fi ~, u ~ 5 ~ 7-Flg. 3 ~ 0) r ~ prb ~ nt ~ r oult ~ t ~ ~ bt ~ nu4 ~ rc u c411 ~ n ~ ul ~ t ~ ol n ~ ~ t ~ Pl ~. 4 t .; 25 ~) r ~ pr ~ r ~ t ~ le ~ r ~ U1 ~ 4t ~ $ 1m ~ 1 ~ 1st with 1 ~ ocl ~ t ~ or ~ ~) S t PGP ~ an 1 ~ ~ o ~ n ~ t ~ - ~ F ~ S. 5 SX S003 repr ~ nt ~ un d ~ l 411 d ~ o ~ u; a ~ n r ~ n, ~ r ~ t lon col-r ~ l ~ pord ~ nt 3 14 ~ l ~ ur ~ t 4.
Fl ~ $ ~ 6 and 7 ~ 7 ~ 2gO) reprbsentan cl- ~ r ~. ~ Ul ~ 4t ~
~: lc, ~ t ~ tlon. ~ d ~ pl ~ le: ~ obt ~ n ~ J re, ~ p ~: tlv ~ m ~ nt ovec a ~ ~ Otl.Jt lon phy; ilûlozlqu ~ t ~ on ~ t ~ v ~ a oc l ~ tlc, n ~ FCiF ~ tr ~ n ~ sul f ~ ~.
',.'' ... . . . . . . . ............................ ..
:. . . `~.
~ CV aY'X ~ rox T ~ l ~ copl ~ r 702U, 10- 4-89; 11:49; 33 1 874 51 37 ~, ~, S &H; ~ 1 . . .
"'2q ~ .. 3 ¢' ~ i5 CO
V ~ n3 1 ~, ~ xp ~ rler ~ cec ropport ~ ~ nr ~ f ~ r ~ anc ~ au ;;
s 3 ~ S, we have utllls ~ ~ es m ~ e ~ o ~ pos ~ tlons qu ~
c ~ lle ~ lndl ~ u ~ ut ~ ble ~ u 4.
L ~ an ~ ly, ~ h ~ stolc, gique d4D ~ on ~ r ~ q ~ e 1 '~ sl ~ ocLatlon ~ + VS accelerates the ét ~ p ~! A tr ~ dlt10n ~ lleQ of 1 elcatrlsotion d, ~ rrn ~ - ~ plderD ~ eu and eua: Dnte 1 ~ qu ~ de.
t ~: 3us reconstl ~ u ~ - ~ p ~ r ratio ~ xo ~ ~ nt ~ tlons t, ~ oin.s (~ oll ~ 3 ~ ne sf ~ ul ~. A ~ nsl, in pl S ~ -lnc6 of F ~ F +
~ e: ~ trane, a ~ colonl ~ t lon very ~ rapld ~ ~ I Day ~ from ~ a c ~ t ~ gorleO c ~ lalre ~ ~ n ~ lronnante $ ~ 1l ~ obl4s ~ eo, sru ~ cul ~ LrC3 lls ~;) e:, ~ o ~ s ~ rv ~ e ~ por Sr d ~ st ~ ssUs ~ ln3 ;. ~ Lns, et, ~ n partlcull ~ r, ~ p ~ rt ~ r du con, ~ onet1 ~ ~ u pl anc her mus ,: ulo 1 re ~ str ~ 3 ~ c ~ nt.
~ an ~ m ~ k ~ mps ~ fl ~ ure 5, a n ~ o4n ~ iea ~ en ~ sQ
1 ~ allows ~ u tLss ~ - in f ~ r. ~ Atlen to be co on ~ p ~ r a ~ .nslt ~
t ~ for., ~ de capill ~ ire ;; ~ an ~ sulns ~ d ~ l ~ n ~ p ~ r le ~ hlffre ct ~ r ~ fbrence 10 ~ ur cett ~ fl ~ re), d ~ ll 1 ~; t ~ s.su: ~ en r. ~ n ~ r ~ Slon dk ~ ign ~ s by le ehlffr ~ ldr ~ fkrenc ~ 11. / ~ u L ~ ou ~ dc ~ ~ our: ~ ~ contr ~ 5 h ~ for the ~ t ~ oin ~
.0 r ~ plth ~ l ~ 6 ~ t ~ on cngagke ~ partlr t ~ 1 ~ pldeeme d ~ re ~
J ~ 1 ~ pl ~ lc arrives ~ confronts ~ ent. The father is S,;, ~ t, 31em ~ nt réor ~ an ~ s ~ ~ 3t il pr ~ entQ u ~ d ~ nslt ~ norm ~ l ~
~ f.3u ~ -e ~, 4 ~ 1ne J ~ r ~ cor ~ .p ~ otlveo ~ ent ~, IX tg3toln ~ t 4 1 d ~ n ~ lt ~ c ~ llul ~ b, ~ uco ~ p plu ~ f ~ l ~ re 3 ~, 5 5 ~ .ne ~ our ~. Ce ~ meme3 l ~ lu ~ tr ~ tlor ~ ts r ~ nt 1 '~ b ~ nce d ~
r ~ tr ~ t ~ on d ~ s bor ~ s dQ 1 ~ plzL ~ powr ~ t8 punchs ~ t- ~ lt ~: 7 p ~ r assocl4tlon F ~ F ~ D5, contr ~ lrem ~ ne ux t ~ olns qul C ~ th ~ 3nt pat- r ~ tr ~ ctlon le. ~ Tls ~ u3 exc 8 ~.
The clc ~ tr ~ sation of ~ plala ~ b ~ onue ~ p ~ r scarlflcatlon ~ t ~ valu ~ ep ~ ru ~ e ~ tud hlotclo ~ lqu ~
.3ffe ~ tu ~ 5 Jour3 ~ pr ~ s ~ 'op0ratlon. ct traltQmer, tt con ~ l3te 2n a ~ ~ eule ~ ppllc ~ t ion top ~ eu ~ tJ nl ~ o ~ td ~ 1 ~ le ~ lon l ~ a - m ~ m ~ of the opkt ~~ tlon. L ~ sr ~ sult ~ .o ~ have ~ r ~ ~ u ~
1 ~ 5 tl3ur ~. ~ 6 and 7 c ~ u $ mont ~ nt le: a tl ~ iiu ~ de 1 ~ p ~ y ~ nt ; ~ 5 received a ~ s- ~ lutlon phyJ.lolo ~ lqu ~ t ~ mo ~ ~ r ~ t 1 ~ aJo ~ t Ivn d ~ b ~ GF re,: om ~ 1n ~ nt ~ de ~; r ~ n ~ ~ ulf ~ e <~ n, ~
,.
R ~ V ~ r: x ~ rox -lel ~ copler ~ lu ~ u ilU ~ 51; 33 1 ~ 74 51 37 ~ q, S & H: #
Xl .r: ri ~ ~ t 5 ~ e cle: ~ tr ~ n ~, ulf ~ te pD ~) for 1 r L ~ ru ~ ~ l '.' .
'1 e ~ t ~ n- ~ t er. ~ Ue the presence of 1 a ~ scc S ~ tl Gn lndui ~ 1 'er.clench ~ ment of: a mkcarilsme3 c cntrlciel ~ qui ~ etnblent totnlem ~ nt t ~ rminé3 au 3 ~ n ~ e Jo r ~ uiv ~ nt 14 bl ~: 3on ~ ure ~). L. ' ~ plder ~ e p4r ~ P: i ~ aent recoR ~ t ltu ~
~, urn ~ have a ~ erme ~ ns ~, prS ~ nt ~ n ~ W ~ l ~ orgMnl ~ t lon 1r ~ dl:, cerna ~ 1e des tlssu3 envlronnDnt. ~ nr ~ v ~ nch ~
cl- ~ atri ~ tlor ~ ~ u té ~ l ~ oln Cflgur ~ 6 ~ t ~ r3 las o ~ st ~ 6 'a t ~ mp ~ n ~ chevee. L'~ pld ~ r ~ plu3 1 ~ ~ ot p ~ r ~ tlell ~ -ment r ~ con ~ tltu ~ t denP ~ s ~ u ~; -Joc ~ t present ~
., lt ~ ~ r ~ 3 ldche et un ~ ~ r ~ nl ~ t ~ or no ~ hlclu ~ c de., c e11 ~ n ~ cl ~ os ~ s.
L '~ ocidtton ~ SF + dextrun ~ ulf ~ t ~ pr ~ nt ~
: t ca ~ .r, rn ~ r pui.; ~ ta ~, r ~ nt c ~ trls ~ nt In I ~ cc; ~ l ~ r ~ n-. ~ 'une ~, 3r; ~ r, ~ r ~ sus nutllr ~ l ~ rt ~ r ~ tlf, ~ t per. ~ -3 ~ t4nt ~ 'outr ~ p ~ rt a qur31Lt ~ increased ~ d ~ 1 ~ C cotrl ~ otlon p ~ r , s ~ n- a; 3- ~ all F, h ~ n ~ m ~ n ~ de tr ~ trac ~ l I ~ b unq It ~ obili: ~ atlon r ~ pld ~ -J ~, dlffér ~ nte3 c ~ t ~ orl ~ sc ~ liull ~ lr ~ :, n ~ -c; ~.;, 1r ~ ~ la r ~ st ~ ur ~ t'on ti ~ sul ~ lr ~.
P. ~ ur mie ~ 1 ll ust r ~ r 1 obJ ~ 2t o prb ~ ent o irr ~ nt, ~ n,, ~ n ~ en ~ cl ~ lr ~ m ~ l ~ t ~ n4nt u, 21q ~ n) pl ~ e:.
l: r ~ tL; ~ .rl ~ Ji r: e siont en ~ uc ~ no f4 ~; i ~ from $ tlnS3 ~ ~ n llrnltsr 1 ~ p ~ r; ~.
; ~ .'i G, '. ~ "R ~ ipl ~ r ~ p ~ ra ~ on p' ~ cr em ~
~ n pr ~ por ~ la composit ~ on su v-nte:
F ~ F.,., ................, ..... .. ,, .. ,, .., 10) I ~, ~ O! :: ax ~ r4ne ~ ul ~ t ~ ~ n 'P5660. ~ Uc ~ 4 42 ~ u ~ 51 ~ ns). ~ O m ~
C ~ rl ~ oxy ~, ~ th) ~ lc ~ lo ~ .. ............. ''. 5 ~, ~
ED U PUr 1fi ~: st ~ r11 * ~ t ~ pyr ~ n ~ a ...... 1 ~ ml ~ n ot ~ tlent. ~ insl un ~ ~ r ~ ma qe 1 'on ~ ppllqu ~ rT ~ rl ~ lt) ,. ct ~ iolr ~, ur ur ~ 3 pl ~ l ~ dq Syp ~: sci ~ r ~ Lc tLon, ou un r4t. ~ n t; ~ ur.e ~ trl ~, 3tlc. ~ n ~ pr ~ 3 3 ~ YES ~ c ~ traltornl ~ nt.
`:. , ',,' ~ ,,. ',;,. , ',',. .,. ,, ': ~,.
RCV B ': Xerox T ~ l ~ copi ~ r 7 ~ 20; 10- 4-as, 11:52 .33 1 ~ 74 51 37 ~ C., S ~ H: # 3 r 2; 1;
6. ~
r ,, ~! ~ r ~ r. ? P ~ ~ .p. ~, R ~ Jr ~ n ~ m. ~
~ ~ s ~ pp ~ rt ue ~ c, t un fll ~ coll ~ ne ~: ~. ~ ti .: te rlU ~ S (i ~ S. ~ cl ~ t ~ "F ~ t ~ C ~ L ~ n) t; ~ rllm ~ t, i: n ~ rC3rl ~ par ~ dsorptlerl pa ~ s ~ v ~ 3 du m ~ ll ~ se FGF-d ~ xtr; ~ ne ! i 3ulf ~ t ~ w dPwn ~ prepol tlons s ~ lv ~ n ~
Fr, F .... ~ ,,,,, ......................., .. 10, u, ~ e,; tran ~ ~ ulfat ~ ~ n- ~ 5 ~ 50 ~ u catal 3aSu ~ 51zm ~ O
~ al ~ 2. 1 ~ J. ~ l de s ~ ru ~ physlologlqu ~ ~ t ~ lo ~ t ~ pyr ~ g ~
r ~ fblt lr ~ cuber p ~ n ~ nt 3 ~ ~ lnute.a ~ 4 ~ CIe p ~ n ~ nt obtained, d ~, eupabl ~ ~ 'a forn ~ e ~ la pl ~ t nsu1, t ~ a sc ~ eu ~
v ~ d. ~ bundled.
It p ~ t ~ Sr ~ elppl1q ~ a. ~ Ce: ~ 'yl ~ r4 ~ ion ~
L, rOlur ~ 3s, d * c ~ upure. ~ And plal ~, prol ~ nd ~.
F. ~ t, ~ l, r. ~~ r ~ nf ll ~ ~
L ~ rr. ~ E pr ~ par ~ t lon qu ~ cl- ~ s $ u ~, 41n ~: oua le tnr5; n ~ me:! ~ op ~ roire, p ~ u ~ nt serve ~ impr ~ win utur ~ c ~ lrur31ce ~ 1 ~ t ~; F ~ ~ ehlcon - V1cl yl E ~ VZ). L ~ fll.
~ 7 iutrul-L ot ~ held e: jt used ~ bl ~ ~ n chtru ~ ~ o.
15l ~ lE, 4: Fl ~ r ~ tl ~ n,, ~ 'un .411 ~ r ~
We pr ~ p ~ r ~ e 13 compos' ~ I ~ n su vunte;
Y ~. ~ `..,. ,,,,,. ,,,,,,,,,,,,, .............. ~ 0 r.3 D ~: ~ tran ~ 6ulfi ~ t ~ ~ n 'D5650 cu C ~ ltA c13ue S ~ .sm ~). 150 L ~ rrn ~ 3 ~ rtlfici ~ oe .......... ............. 3 ml 011 ~ ff ~ ctu ~ In rn ~ l ~ nge p ~ r ~ lyophlll ~ tiorl, pu ~ n 4Jol ~ tr: 3 ml of e ~ u purl ~ i ~ e: ~ t ~ llo apyr ~ or cnt d ~ I'em7p1ci.
The coll. ~ Ri3 a.;. T 4ppliqu ~ ~ nx lcts c ~ $ d 'ul ~ ær, ~ L ion ~ -7 1 ~ l .orn ~ e, 4 rals, ~ n de ~ euY. ln ~ tlll tl ~ n $ p ~ r ~ our.
'~ 5
Claims (16)
500 mg par millilitre ou gramme de mélange final. 4 - Composition according to claim 2, contain at least one medium-insoluble dextran sulfate aqueous, characterized in that the dextran (s) sulfates are present at a concentration of 0.1 µg at 500 mg per milliliter or gram of final mixture.
4, caractérisée par le fait qu'elle renferme de 0,01 ng à
300 µg d'au moins une forme active de FGF, par millilitre ou gramme de mélange final FGF/dextrane sulfate. 5 - Composition according to one of claims 1 to 4, characterized in that it contains from 0.01 ng to 300 µg of at least one active form of FGF, per milliliter or gram of final FGF / dextran sulfate mixture.
5, caractérisée par le fait que le FGF est un FGF purifié
sous ses formes acide ou basique, ou un mélange des deux, ou encore un dérivé ou un analogue d'au moins l'une de ces formes. 6 - Composition according to one of claims 1 to 5, characterized in that the FGF is a purified FGF
in its acidic or basic forms, or a mixture of the two, or still a derivative or analog of at least one of these shapes.
6, caractérisée par le fait que l'association FGF/dextrane sulfate est incorporée dans des supports physiologiquement acceptables pour des applications in vivo. 7 - Composition according to one of claims 1 to 6, characterized by the fact that the FGF / dextran association sulfate is incorporated into physiologically supports acceptable for in vivo applications.
à former un écran protecteur de la cornée. 12 - Composition according to one of claims 8 and 9, characterized in that it is presented under a form applicable to the cornea, eye drops or gel intended to form a protective screen for the cornea.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8813224A FR2637501A1 (en) | 1988-10-07 | 1988-10-07 | STABILIZED COMPOSITION BASED ON GROWTH FACTORS OF THE FGF FAMILY AND DEXTRANE SULFATE AND ITS APPLICATIONS |
FR8813224 | 1988-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2000254A1 true CA2000254A1 (en) | 1990-04-07 |
Family
ID=9370814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA 2000254 Abandoned CA2000254A1 (en) | 1988-10-07 | 1989-10-06 | Stabilized compound of fgf-family growth factors and dextran sulfate and it a applications |
Country Status (3)
Country | Link |
---|---|
CA (1) | CA2000254A1 (en) |
FR (1) | FR2637501A1 (en) |
WO (1) | WO1990003797A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4121043A1 (en) * | 1991-06-26 | 1993-01-07 | Merck Patent Gmbh | BONE REPLACEMENT MATERIAL WITH FGF |
CA2071137A1 (en) * | 1991-07-10 | 1993-01-11 | Clarence C. Lee | Composition and method for revitalizing scar tissue |
CA2080537A1 (en) * | 1991-10-21 | 1993-04-22 | David B. Volkin | Stabilized topical acidic fibroblast growth factor formulation |
US5348941A (en) * | 1992-04-01 | 1994-09-20 | Merck & Co., Inc. | Stabilizers for fibroblast growth factors |
US5464815A (en) * | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
FR2877565A1 (en) * | 2004-11-09 | 2006-05-12 | Oreal | Nontherapeutic use of a dextran sulfate, to prevent and/or to decrease cutaneous reaction, or to alleviate the effect of an irritant in a cosmetic or dermatological composition |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0193917A3 (en) * | 1985-03-06 | 1987-09-23 | American Cyanamid Company | Water dispersible and water soluble carbohydrate polymer compositions for parenteral administration |
CA1294546C (en) * | 1986-04-23 | 1992-01-21 | John S. Sundsmo | Wound healing composition containing collagen |
-
1988
- 1988-10-07 FR FR8813224A patent/FR2637501A1/en not_active Withdrawn
-
1989
- 1989-10-06 CA CA 2000254 patent/CA2000254A1/en not_active Abandoned
- 1989-10-06 WO PCT/FR1989/000516 patent/WO1990003797A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5492894A (en) * | 1991-03-21 | 1996-02-20 | The Procter & Gamble Company | Compositions for treating wrinkles comprising a peptide |
Also Published As
Publication number | Publication date |
---|---|
FR2637501A1 (en) | 1990-04-13 |
WO1990003797A1 (en) | 1990-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2421208C2 (en) | Cell and cell extract introduction for rejuvenation | |
EP2340856B1 (en) | Cosmetic or dermatologic formulation comprising a nutrient medium phase | |
CA2597339C (en) | Use of silymarine and/or the constituents thereof as promoters of the pigmentation of the skin or hair | |
JP2016528911A (en) | Conditioned medium derived from stromal cells, method, preparation and application for obtaining said conditioned medium composition | |
CA2000254A1 (en) | Stabilized compound of fgf-family growth factors and dextran sulfate and it a applications | |
KR20220011861A (en) | Composition for preventing, suppressing, alleviating, improving or treating skin toxicity induced by chemotherapy or radiation comprising exosomes derived from stem cell or lyophilized formulation thereof as an active ingredient | |
KR20200013574A (en) | Composition for reducing sebum release comprising an exosome derived from stem cell as an active ingredient | |
KR102311832B1 (en) | Composition for improving skin and preventing hairloss and method for preparing the same | |
FR3018191A1 (en) | COSMETIC USES OF SWERTIAMARIN | |
JP2004091397A (en) | Skin aging-preventive composition for preventing and ameliorating epidermis flattening | |
EP3829607A1 (en) | Conditioned medium and extracellular matrix compositions and uses thereof | |
US20140155346A1 (en) | Cosmetic and/or dermatological use of oligosaccharide compounds for preventing and treating stretch marks | |
US20090274638A1 (en) | Cosmetic use of a c-glycoside derivative in combination with ascorbic acid | |
EP3442659A1 (en) | Cosmetic use of a khaya senegalensis extract | |
CN110248648B (en) | Application of cell membrane binding signal factor | |
EP2070531B1 (en) | Pharmaceutical preparation containing histamine H2-receptor antagonists having wound healing activity at low doses | |
KR102272303B1 (en) | Method for impregnating micropore of spicule with liposome | |
CA3140206A1 (en) | Method for isolating molecules contained in the organomineral layers of shells of bivalve marine mollusks | |
KR102364823B1 (en) | Cosmetics for Skin Cell Regeneration | |
KR20200016183A (en) | Method for skin care using the combination of skin peeling and treating exosomes onto skin | |
WO2021177430A1 (en) | Hair growth promoting composition and/or gray hair ameliorating composition | |
Eriksson | Regeneration of the epidermis in Lyell's syndrome. A light-and electron-microscopic study | |
KR102292608B1 (en) | Use of conditioned media containing high concentration of extracellular vesicles with enhanced functions for alleviating and preventing hair loss | |
EP2273965A1 (en) | Composition for the treatment of seborrhoeic conditions | |
JP2025023925A (en) | Use of cell membrane-associated signaling factors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |